User Image Cart Icon 0 Search Image

BIGUANIDE | BIGUANIDES

  1. Biguanide-associated lactic acidosis: case report and review of the literature
  2. Lactic acidosis in biguanide-treated diabetics: a review of 330 cases
  3. Biguanides and NIDDM
  4. Pharmacophoric features of biguanide derivatives: an electronic and structural analysis
  5. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide
  6. Outcome of Acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine
  7. Re-evaluation of a biguanide, metformin: mechanism of action and tolerability
  8. Biguanide
  9. The response of Escherichia coli to exposure to the biocide polyhexamethylene biguanide
  10. Metformin: a new oral biguanide
  11. New polymeric biocides: synthesis and antibacterial activities of polycations with pendant biguanide groups
  12. Interaction of a polymeric biguanide biocide with phospholipid membranes
  13. Structural requirements of guanide, biguanide, and bisbiguanide agents for antiplaque activity
  14. Physical and chemical characterization of poly (hexamethylene biguanide) hydrochloride
  15. Comparing two polymeric biguanides: chemical distinction, antiseptic efficacy and cytotoxicity of polyaminopropyl biguanide and polyhexamethylene biguanide
  16. Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis
  17. Effect of a polyhexamethylene biguanide mouthrinse on bacterial counts and plaque
  18. … analysis of zigzag polyhexamethylene biguanide, polyhexamethylene adipamide, polyhexamethylene biguanide gauze and polyhexamethylene biguanide …
  19. Polyhexamethylene Biguanide (PHMB): An Addendum to Current Topical Antimicrobials.
  20. Biguanide hydrochloride
  21. Vanadyl–biguanide complexes as potential synergistic insulin mimics
  22. Synergism within polyhexamethylene biguanide biocide formulations
  23. Biguanide related compounds in traditional antidiabetic functional foods
  24. Biguanide treatment increases the number of insulin-receptor sites on human erythrocytes
  25. Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro
  26. In vitro and in vivo modulation of alternative splicing by the biguanide metformin
  27. Oxygen consumption is depressed in patients with lactic acidosis due to biguanide intoxication
  28. … corneal staining associated with the use of balafilcon silicone-hydrogel contact lenses disinfected with a polyaminopropyl biguanide-preserved care regimen
  29. Bactericidal effects of polyhexamethylene biguanide against intracellular Staphylococcus aureus EMRSA-15 and USA 300
  30. Cysticidal effect on Acanthamoeba and toxicity on human keratocytes by polyhexamethylene biguanide and chlorhexidine
  31. Effects of the biguanide class of oral hypoglycemic agents on mouse embryogenesis
  32. Polybiguanides, particularly polyethylene hexamethylene biguanide, have activity against human immunodeficiency virus type 1
  33. Antidiabetic and antimalarial biguanide drugs are metal-interactive antiproteolytic agents
  34. The activation of the biguanide antimalarial proguanil co‐segregates with the mephenytoin oxidation polymorphism‐a panel study.
  35. An EPR study of copper (II)-substituted biguanide complexes. Part III
  36. Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling
  37. Polyhexamethylene biguanide exposure leads to viral aggregation
  38. … biologically active molecules with phospholipid membranes: I. Fluorescence depolarization studies on the effect of polymeric biocide bearing biguanide groups in the …
  39. Reduction of bacterial burden and pain in chronic wounds using a new polyhexamethylene biguanide antimicrobial foam dressing: clinical trial results
  40. Studies on synthetic antimalarial drugs: X.—some biguanide derivatives as new types of antimalarial substances with both therapeutic and causal prophylactic activity
  41. Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis
  42. Polyhexamethylene biguanide functionalized cationic silver nanoparticles for enhanced antimicrobial activity
  43. Biguanide related lactic acidosis: incidence and risk factors.
  44. Environmental fate of polyhexamethylene biguanide
  45. Analysis of polyhexamethylene biguanide in multipurpose contact lens solutions
  46. Cooperativity in the binding of the cationic biocide polyhexamethylene biguanide to nucleic acids
  47. Is it time to test biguanide metformin in the treatment of melanoma?
  48. The biocide polyhexamethylene biguanide remains an uncommon contact allergen: Recent multicentre surveillance data
  49. Toxicological assessment of polyhexamethylene biguanide for water treatment
  50. Combined treatment of Acanthamoeba keratitis with propamidine, neomycin, and polyhexamethylene biguanide
  51. Development and application of an in vitro susceptibility test for Acanthamoeba species isolated from keratitis to polyhexamethylene biguanide and chlorhexidine
  52. The effect of a polyhexamethylene biguanide mouthrinse compared to an essential oil rinse and a chlorhexidine rinse on bacterial counts and 4‐day plaque regrowth
  53. Antimicrobial electrospun membranes of chitosan/poly (ethylene oxide) incorporating poly (hexamethylene biguanide) hydrochloride
  54. Effect of biguanide treatment in obese children.
  55. Antiviral properties of polymeric aziridine-and biguanide-modified core–shell magnetic nanoparticles
  56. Biguanide‐induced changes in Acanthamoeba castellanii: an electron microscopic study
  57. Resistance, biguanide sorption and biguanide‐induced pentose leakage during encystment of Acanthamoeba castellanii
  58. Effects of ionic and surfactant agents on the antimicrobial activity of polyhexamethylene biguanide
  59. The effectiveness of topical polyhexamethylene biguanide (PHMB) agents for the treatment of chronic wounds: a systematic review
  60. Metformin, the rebirth of a biguanide: mechanism of action and place in the prevention and treatment of insulin resistance
  61. Methyl succinate antagonises biguanide‐induced AMPK‐activation and death of pancreatic β‐cells through restoration of mitochondrial electron transfer
  62. In vitro efficacy of a polyhexamethylene biguanide‐impregnated gauze dressing against bacteria found in veterinary patients
  63. Therapeutic effects of biguanide vs. statin in polycystic ovary syndrome: a randomized clinical trial.
  64. The safety and efficacy of bacterial nanocellulose wound dressing incorporating sericin and polyhexamethylene biguanide: in vitro, in vivo and clinical studies
  65. Biguanide/Pd (OAc) 2 immobilized on magnetic nanoparticle as a recyclable catalyst for the heterogeneous Suzuki reaction in aqueous media
  66. Acanthamoeba keratitis in New Zealand, including two cases with in vivo resistance to polyhexamethylene biguanide
  67. In-vitro activity of polyhexamethylene biguanide (PHMB) against fungal isolates associated with infective keratitis
  68. Electronic and infrared spectra of biguanide complexes of the 3d-transition metals
  69. Metformin (dimethyl-biguanide) induced DNA damage in mammalian cells
  70. Mucoadhesive system formed by liquid crystals for buccal administration of poly (hexamethylene biguanide) hydrochloride
  71. Energy metabolism determines the sensitivity of human hepatocellular carcinoma cells to mitochondrial inhibitors and biguanide drugs
  72. Biguanide-Atovaquone Synergy against Plasmodium falciparum In Vitro
  73. Study of epigenetic properties of Poly (HexaMethylene Biguanide) hydrochloride (PHMB)
  74. The successful synthesis of biguanide-functionalized mesoporous silica catalysts: excellent reactivity combined with facile catalyst recyclability
  75. Determination of chlorhexidine digluconate and polyhexamethylene biguanide in eye drops by capillary electrophoresis with contactless conductivity detection
  76. Killing acanthamoebae with polyaminopropyl biguanide: quantitation and kinetics
  77. Evaluation of polyhexamethylene biguanide (PHMB) as a disinfectant for adenovirus
  78. Plasma biguanide levels are correlated with metabolic effects in diabetic patients
  79. Effect of surfactants, temperature, and sonication on the virucidal activity of polyhexamethylene biguanide against the bacteriophage MS2
  80. The biguanide compound metformin prevents desensitization of human pancreatic islets induced by high glucose
  81. Determination of biguanide groups in polyhexamethylene biguanide hydrochloride by titrimetric methods
  82. Double-biguanide therapy for resistant Acanthamoeba keratitis
  83. Corneal penetration of polyhexamethylene biguanide and chlorhexidine digluconate
  84. Antifungal activities of polyhexamethylene biguanide and polyhexamethylene guanide against the citrus sour rot pathogen Geotrichum citri-aurantii in vitro and in vivo
  85. Benefit of polyhexamethylene biguanide in Fusarium keratitis
  86. Inhibiting stemness and invasive properties of glioblastoma tumorsphere by combined treatment with temozolomide and a newly designed biguanide  …
  87. … prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide
  88. The toxicity and general pharmacology of N1-p-chlorophenyl-N5-isopropyl biguanide
  89. The effect of a polyhexamethylene biguanide mouthrinse compared with a triclosan rinse and a chlorhexidine rinse on bacterial counts and 4‐day plaque re‐growth
  90. Efficacy and safety of once‐weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once‐daily insulin glargine in J apanese patients …
  91. Bactericidal core-shell paramagnetic nanoparticles functionalized with poly (hexamethylene biguanide)
  92. Preparation of Triazines by the Reaction of Biguanide and Esters1
  93. Metal and non-metal biguanide complexes
  94. Synthesis of biguanide-functionalized single-walled carbon nanotubes (SWCNTs) hybrid materials to immobilized palladium as new recyclable heterogeneous …
  95. An expedient and facile one-step synthesis of a biguanide library by microwave irradiation coupled with simple product filtration. Inhibitors of dihydrofolate reductase
  96. In vitro and in vivo effects of polyhexamethylene biguanide against herpes simplex virus infection.
  97. Enhanced secretion of glucagon-like peptide 1 by biguanide compounds
  98. The structure of biguanide complexes of boron
  99. Synthesis of boron heterocycles from biguanide
  100. In vitro metabolism of the biguanide antimalarials in human liver microsomes: evidence for a role of the mephenytoin hydroxylase (P450 MP) enzyme.
  101. A new approach for the treatment of bacterial vaginosis: use of polyhexamethylene biguanide. A prospective, randomized study
  102. Interaction of a biguanide compound with membrane model interface systems: Probing the properties of antimalaria and antidiabetic compounds
  103. Efficacy of polyhexamethylene biguanide-containing antimicrobial foam dressing against MRSA relative to standard foam dressing
  104. Polyhexamethylene biguanide (PHMB) in the treatment of experimental Fusarium keratomycosis
  105. Evaluation of antimicrobial activity of a polyhexamethylene biguanide‐coated textile by monitoring both bacterial growth (iso 20743/2005 standard) and viability (live …
  106. Interaction of polyhexamethylene biguanide hydrochloride (PHMB) with phosphatidylcholine containing o/w emulsion and consequences for microbicidal efficacy and …
  107. Organic salts of biguanide–An attempt to crystal engineering of novel materials for second harmonic generation
  108. Inorganic salts of biguanide–Searching for new materials for second harmonic generation
  109. mTOR inhibitors and the anti-diabetic biguanide metformin: new insights into the molecular management of breast cancer resistance to the HER2 tyrosine kinase …
  110. Treatment of Nocardia asteroides keratitis with polyhexamethylene biguanide
  111. Malabsorption of vitamin B12 and intrinsic factor secretion during biguanide therapy
  112. A biguanide/Pd-decorated SBA-15 hybrid nanocomposite: Synthesis, characterization and catalytic application
  113. The chemistry of biguanides
  114. Optimization of biguanide derivatives as selective antitumor agents blocking adaptive stress responses in the tumor microenvironment
  115. The comparative clinical performance of a new polyhexamethylene biguanide‐vs a polyquad‐based contact lens care regime with two silicone hydrogel contact …
  116. Lactic acidosis as a serious perioperative complication of antidiabetic biguanide medication with metformin
  117. Biguanide-functionalized mesoporous SBA-15 silica as an efficient solid catalyst for interesterification of vegetable oils
  118. Interleukin-8 production in human adipose tissue. Inhibitory effects of anti-diabetic compounds, the thiazolidinedione ciglitazone and the biguanide metformin
  119. Synthesis of some heterocyclic derivatives of biguanide with antibacterial activity
  120. NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo
  121. A novel approach for immobilization of polyhexamethylene biguanide within silica capsules
  122. Biguanide derivatives: agonist pharmacology at 5-hydroxytryptamine type 3 receptors in vitro.
  123. Rapid, simple and stability-indicating determination of polyhexamethylene biguanide in liquid and gel-like dosage forms by liquid chromatography with diode …
  124. Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria
  125. A colorimetric assay for the determination of polyhexamethylene biguanide in pool and spa water using nickel–nioxime
  126. Effects of a Biguanide (Metformin) on Vitamin B12 and Folic Acid Absorption and Intestinal Enzyme Activities
  127. The relative effectiveness of guanidinium and some biguanide slats as denaturants Assessment against penicillinase
  128. A new non-invasive approach based on polyhexamethylene biguanide increases the regression rate of HPV infection
  129. Spectrophotometric (UV) investigation on biguanide and substituted biguanides
  130. Extreme basicity of biguanide drugs in aqueous solutions: Ion transfer voltammetry and dft calculations
  131. Biodegradability of end-groups of the biocide polyhexamethylene biguanide (PHMB) assessed using model compounds
  132. 149. Synthetic antimalarials. Part X. Some aryl-diguanide (“-biguanide”) derivatives
  133. … antibacterial efficacy of poly (hexamethylene biguanide) on cotton. Part 3: Reduction in the antibacterial efficacy of poly (hexamethylene biguanide) on cotton, dyed …
  134. Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
  135. Ultraviolet spectral studies on metal biguanide complexes
  136. Maximum inhibitory dilution of mouthwashes containing chlorhexidine and polyhexamethylene biguanide against salivary Staphylococcus aureus
  137. Spectroscopic studies on the interaction of polymeric in-chain biguanide biocide with phospholipid membranes as probed by 8-anilinonaphthalene-l-sulfonate
  138. Ototoxicity and tolerance assessment of a TrisEDTA and polyhexamethylene biguanide ear flush formulation in dogs
  139. An effective antimicrobial treatment for wool using polyhexamethylene biguanide as the biocide, Part 1: Biocide uptake and antimicrobial activity
  140. Determination of a biguanide, metformin, by high-performance liquid chromatography with precolumn fluorescence derivatization
  141. Albumin reduces the antibacterial activity of polyhexanide-biguanide-based antiseptics against Staphylococcus aureus and MRSA
  142. The resistance of the yeast Saccharomyces cerevisiae to the biocide polyhexamethylene biguanide: involvement of cell wall integrity pathway and emerging …
  143. Biguanide-, imine-, and guanidine-based networks as catalysts for transesterification of vegetable oil
  144. Synthesis and biological evaluation of biguanide and dihydrotriazine derivatives as potential inhibitors of dihydrofolate reductase of opportunistic microorganisms
  145. Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
  146. Poly (hexamethylene biguanide) adsorption on hydrogen peroxide treated Ti–Al–V alloys and effects on wettability, antimicrobial efficacy, and cytotoxicity
  147. Characterization of the biocide polyhexamethylene biguanide by matrix‐assisted laser desorption ionization time‐of‐flight mass spectrometry
  148. Biguanide and squaric acid as pH-dependent building blocks in crystal engineering
  149. Effects of polyhexamethylene biguanide and chlorhexidine on four species of Acanthamoeba in vitro
  150. Novel antimicrobial peptides bacterial cellulose obtained by symbioses culture between polyhexanide biguanide (PHMB) and green tea
  151. Polyhexamethyl biguanide can eliminate contaminant yeasts from fuel-ethanol fermentation process
  152. The crystal and molecular structure of ethylenebis (biguanide) silver (III) sulphate hydrogen sulphate monohydrate [Ag (C6H16N10)] SO4HSO4. H2O
  153. Metformin and other biguanides in oncology: advancing the research agenda
  154. Polyhexamethylene biguanide and calcineurin inhibitors as novel antifungal treatments for Aspergillus keratitis
  155. Understanding the biocide action of poly (hexamethylene biguanide) using Langmuir monolayers of dipalmitoyl phosphatidylglycerol
  156. A simultaneous antimicrobial and shrink resistance treatment of wool woven fabrics using the polymeric biocide polyhexamethylene biguanide
  157. … on consumer safety (SCCS)–2nd Revision of the safety of the use of poly (hexamethylene) biguanide hydrochloride or polyaminopropyl biguanide (PHMB) in cosmetic …
  158. Biguanides. A review of history, pharmacodynamics and therapy.
  159. Potential applications for biguanides in oncology
  160. X‐ray microanalysis of chlorine and phosphorus content in biguanide‐treated Acanthamoeba castellanii
  161. Polyhexamethylene biguanide for treatment of external genital warts: a prospective, double-blind, randomized study
  162. Synthesis and structure of the [MnIV (biguanide) 3] 4+ ion: the simplest source for water-stable manganese (IV)
  163. Reduced cytotoxicity of polyhexamethylene biguanide hydrochloride (PHMB) by egg phosphatidylcholine while maintaining antimicrobial efficacy
  164. Treatment of Acanthamoeba keratitis combined with fungal infection with polyhexamethylene biguanide.
  165. Interaction of some polyhexamethylene biguanides and membrane phospholipids in Escherichia coli
  166. X-Ray crystal structure of ethylenebis (biguanide) silver (III) perchlorate
  167. Effects of polyhexamethylene biguanide and polyquaternium-1 on phospholipid bilayer structure and dynamics
  168. In vitro activities of the biguanide PS-15 and its metabolite, WR99210, against cycloguanil-resistant Plasmodium falciparum isolates from Thailand
  169. The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells
  170. Unexpected like-charge self-assembly of a Biguanide-based antimicrobial polyelectrolyte
  171. Incidence of severe sideeffects during therapy with sulfonylureas and biguanides.
  172. Cyanamide Derivatives. LVII. New Route for Preparation of Biguanide
  173. Complex compounds of biguanides and guanylureas with metallic elements.
  174. Determination of polyhexamethylene biguanide hydrochloride using photometric colloidal titration with crystal violet as a color indicator
  175. Antifungal effect of non-woven textiles containing polyhexamethylene biguanide with sophorolipid: A potential method for tinea pedis prevention
  176. Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand
  177. Complexes of Al (III) and Be (II) with Biguanide
  178. Effect of reactive dyes upon the uptake and antibacterial action of poly (hexamethylene biguanide) on cotton. Part 1: Effect of bis (monochlorotriazinyl) dyes
  179. Increased peritoneal dialysis exit site infections using topical antiseptic polyhexamethylene biguanide compared to mupirocin: results of a safety interim analysis of an …
  180. The biguanide metformin alters phosphoproteomic profiling in mouse brain
  181. A study of the antibacterial activity of some polyhexamethylene biguanides towards Escherichia coli ATCC 8739
  182. Effect of combined secretagogue/biguanide treatment on mortality in type 2 diabetic patients with and without ischemic heart disease
  183. Structural studies on biguanide and related species. Correlation of protonation energy with molecular structure
  184. Anhydrobis-(β-Hydroxyethyl) biguanide-Hydrochloride (ABOB) in Prophylaxis and Suppression of Experimental Influenza.
  185. Acrylic microspheres for oral controlled release of the biguanide buformin
  186. The first report on chemoselective biguanide-catalyzed henry reaction under neat conditions
  187. Alteration of bile acid metabolism and vitamin-B12-absorption in diabetics on biguanides
  188. Polyhexamethylene biguanide in wound care products: a non-negligible cause of peri-ulcer dermatitis
  189. Persistent interactions between biguanide-based compound NB325 and CXCR4 result in prolonged inhibition of human immunodeficiency virus type 1 infection
  190. Specific interactions between the viral coreceptor CXCR4 and the biguanide-based compound NB325 mediate inhibition of human immunodeficiency virus type 1 …
  191. Effect of rosiglitazone and nateglinide on serum glucose and lipid profile alone or in combination with the biguanide metformin in diabetic rats
  192. Should we screen diabetic patients using biguanides for megaloblastic anaemia?
  193. Molecular features of biguanides required for targeting of mitochondrial respiratory complex I and activation of AMP-kinase
  194. Cobalt (III) complexes with biguanide derivatives: Synthesis, structures, and antiviral activity
  195. Kinetics of the silver (I)-catalysed oxidation of H3PO2 with [ethylenebis (biguanide)] silver (III) cation in aqueous perchloric acid solution
  196. The effect of short-term administration of antidiabetic biguanide derivatives on the blood lactate levels in healthy subjects
  197. … reactive dyes upon the uptake and anti bacterial action of poly (hexamethylene biguanide) on cotton. Part 2: Uptake of poly (hexamethylene biguanide) on cotton dyed …
  198. Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention …
  199. Overcoming drug development bottlenecks with repurposing: repurposing biguanides to target energy metabolism for cancer treatment
  200. Structures, electrochemical and spectroscopic properties of ternary ruthenium (II)-polypyridyl complexes with additional carboxylate, biguanide or sulfonamide donors
  201. Serine deprivation enhances antineoplastic activity of biguanides
  202. The biguanide inhibition of D-glucose transport in membrane vesicles from small intestinal brush borders
  203. Absolute configuration of tris (biguanide) chromium (III)
  204. Relationships between chemical structure and antiviral activity of some biguanide derivatives.
  205. Successful use of locally applied polyhexamethylene biguanide as an adjunct to the treatment of fungal osteomyelitis
  206. Insulin and longevity: antidiabetic biguanides as geroprotectors
  207. Phagocytosis Affects Biguanide Sensitivity of Acanthamoeba spp
  208. Structural researches on the chelating behaviour of the biguanide ligand. The crystal structures of Co(C2H6N5)3 · 2H2O and Cu(C2H7N5)2CO3·4H20
  209. 1-(m-chlorophenyl)-biguanide, a potent high affinity 5-HT3 receptor agonist
  210. Clinical trial of 0.02% polyhexamethylene biguanide versus placebo in the treatment of microsporidial keratoconjunctivitis
  211. Antimicrobial activity of short‐and medium‐term applications of polyhexamethylene biguanide, chlorhexidine digluconate and calcium hydroxide in infected immature …
  212. Comparison of the effect of parenteral with oral biguanide therapy on vitamin B12 and bile acid absorption
  213. Selective inhibition of deactivated mitochondrial complex I by biguanides
  214. Kinetics of oxidation of glyoxylic acid by [ethylenebis (biguanide)] silver (III) in aqueous media
  215. Relevance of the OCT1 transporter to the antineoplastic effect of biguanides
  216. The effect of certain biguanide derivatives on the multiplication of myxoviruses in tissue culture
  217. Biguanide-induced lactic acidosis in Finland
  218. Interactions of n-tetraalkylammonium compounds and biguanides with a human renal organic cation transporter (hOCT2)
  219. Thermal, spectral and antimicrobial study on some Cu (II) complexes with ligands bearing biguanide moieties
  220. Clinical evaluation of formamidinyliminourea, a new biguanide oral blood sugar lowering compound: comparison with other hypoglycemic agents
  221. Ultrastructural changes of Acanthamoeba cyst of clinical isolates after treatment with minimal cysticidal concentration of polyhexamethylene biguanide
  222. Potentiometric titration of polyhexamethylene biguanide hydrochloride with potassium poly (vinyl sulfate) solution using a cationic surfactant-selective electrode
  223. An EPR Study of some copper (II) coordination compounds of substituted biguanides. Part IV
  224. Characterization of the urinary polymer‐related material from rats given poly [biguanide‐1, 5‐diylhexamethylene hydrochloride]
  225. Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes (the AddHope2 study): a …
  226. Determination of polyhexamethylene biguanide hydrochloride
  227. Microbial degradation of the biocide polyhexamethylene biguanide: isolation and characterization of enrichment consortia and determination of degradation by …
  228. Crystal and molecular structure of morpholine biguanide hydrochloride
  229. Polynitrogen strong bases: 1-new syntheses of biguanides and their catalytic properties in transesterification reactions
  230. Barrier properties of the Gram‐negative cell envelope towards high molecular weight polyhexamethylene biguanides
  231. Bis-biguanide dihydrochloride inhibits intracellular replication of M. tuberculosis and controls infection in mice
  232. Cardiac but not pulmonary receptors mediate depressor response to IV phenyl biguanide in conscious rabbits
  233. Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 status
  234. Kinetics of oxidation of hydroxylamine by [ethylenebis (biguanide)] silver (III) in aqueous media
  235. Technetium (V) and rhenium (V) complexes of biguanide derivatives. Crystal structures
  236. Evaluation of poly (hexamethylene biguanide. HC1) as a biocide in the food industry
  237. The efficacy and safety of a single dose of polyhexamethylene biguanide gynaecologic solution versus a seven-dose regimen of vaginal clindamycin cream in …
  238. Crystal and molecular structure of morpholine biguanide hydrobromide
  239. Complexes of nickel (III) with biguanide and N′-amidinoisoureas
  240. Attenuation of 1-(m-Chlorophenyl)-Biguanide Induced Hippocampus-Dependent Memory Impairment by a Standardised Extract of Bacopa monniera (BESEB CDRI …
  241. Copper-catalyzed arylation of biguanide derivatives via C–N cross-coupling reactions
  242. All‐cause mortality in diabetic patients treated with combinations of sulfonylureas and biguanides
  243. An effective antimicrobial treatment for wool using polyhexamethylene biguanide as the biocide, part 2: further characterizations of the fabrics
  244. Some new aspects on the interaction of hypoglycemia-producing biguanides with biological membranes
  245. Evaluation of a combination of sodium hypochlorite and polyhexamethylene biguanide as an egg wash for red-eared slider turtles (Trachemys scripta elegans) to …
  246. Biguanides inhibit complex I, II and IV of rat liver mitochondria and modify their functional properties
  247. Curing of liquid crystalline epoxy resins with a biguanide
  248. Polyhexamethylene Biguanide Dressing–Another Promising Tool to Reduce Catheter-related Bloodstream Infection
  249. Biguanides and thiazolidinediones inhibit stimulated lipolysis in human adipocytes through activation of AMP-activated protein kinase
  250. ATTEMPTS TO FIND NEW ANTIMALARIALS. XXII. BIGUANIDE DERIVATIVES OF PHENANTHRENE1
  251. Complexes of biguanide and malonic-diamidine
  252. Specific inhibition of gluconeogenesis by biguanides
  253. Effect of biguanides on intestinal absorption of glucose
  254. Metformin: a biguanide.
  255. Biguanides
  256. Ruthenium-catalyzed synthesis of tri-substituted 1, 3, 5-triazines from alcohols and biguanides
  257. ATTEMPTS TO FIND NEW ANTIMALARIALS. XXI. GUANIDINE AND BIGUANIDE DERIVATIVES OF PHENANTHRENE1,2
  258. Binding of some polyhexamethylene biguanides to the cell envelope of Escherichia coli ATCC 8739.
  259. Assessment of the mode of action of polyhexamethylene biguanide against Listeria innocua by Fourier transformed infrared spectroscopy and fluorescence …
  260. Haemodialysis in the treatment of biguanide-induced lactate acidosis (author’s transl)
  261. Surgical site infections. Effectiveness of polyhexamethylene biguanide wound dressings
  262. UK prospective study of therapies of maturity-onset diabetes: I. Effect of diet, sulphonylurea, insulin or biguanide therapy on fasting plasma glucose and body weight …
  263. Mixed-ligand complex formation equilibria of CuII with biguanide in presence of glycine as the auxiliary ligand
  264. Syntheses, crystal structures and properties of copper (II) complexes of 1-amidinoisourea and biguanide nitrates
  265. Effect of discontinuation of biguanide therapy on metabolic control in maturity-onset diabetics
  266. Biguanides and sulfonylureas as combination therapy in NIDDM
  267. Effect on dental plaque formation and some in vitro properties of 12 bis‐biguanides
  268. Treament of biguanide-induced lactic acidosis with dichloroacetate. 3 case histories.
  269. Antimicrobial action of biguanides on the viability of Acanthamoeba cysts and assessment of cell toxicity
  270. Antidiabetic medications in overdose: a comparison of the inquiries made to a regional poisons unit regarding sulfonylureas, biguanides and insulin.
  271. Synthesis, biological activity, and QSAR studies of antimicrobial agents containing biguanide isosteres
  272. Action of Biguanides, Phenols and Detergents on Escherichia coli and its Spheroplasts
  273. Molecularly imprinted solid-phase extraction for the screening of antihyperglycemic biguanides
  274. Synthesis and evaluation of 1-substituted-biguanide derivatives as anti-diabetic agents for type ii diabetes insulin resistant
  275. NCW2, a gene involved in the tolerance to polyhexamethylene biguanide (PHMB), may help in the organisation of β-1, 3-glucan structure of Saccharomyces …
  276. Simple electron capture gas chromatographic method for the determination of oral hypoglycemic biguanides in biological fluids
  277. Modern approach to metabolic rehabilitation of cancer patients: biguanides (phenformin and metformin) and beyond
  278. Kinetics of Oxidation of Azide by [Ethylenebis(biguanide)]silver(III) in Aqueous Acidic Media
  279. Time survivor study of Escherichia coli with polyhexamethylene biguanide on cotton
  280. Anti-Pneumocystis carinii activity of PS-15, a new biguanide folate antagonist
  281. Circular Dichroism of Mixed Biguanide Ethylenediamine Cobalt (III) Complexes
  282. Effects of insulin, biguanide antihyperglycaemic agents and β-adrenergic agonists on pathways of myocardial proteolysis
  283. The structure and absolute configuration of (+) 589-tris (biguanide) cobalt (III) trichloride monohydrate Co (C2H7N5) 3Cl3. H2O
  284. Central anti-diabetic action of biguanide and thizolidinediones in D-glucose fed and streptozotocin-treated mouse models
  285. The effect of phenyl ethyl biguanide in vivo and in vitro on gluconeogenesis and ammonia production in rats
  286. Crystal and molecular structure of a new biguanide metal complex, [Cu(AMNH)2]Cl2
  287. BIGUANIDE AND THIOUREA DERIVATIVES OF QUINOLINE1
  288. Carbohydrate biguanides as potential hypoglycemic agents.
  289. The lethal effects of biguanides on cysts and trophozoites of Acanthamoeba castellanii
  290. Evaluation of cellulose and polyhexamethylene biguanide (Suprasorb® X+ PHMB) in therapy of infected wounds
  291. The combination of dulaglutide and biguanide reduced bodyweight in J apanese patients with type 2 diabetes
  292. Thermal decomposition of the biguanide complexes of the 3d-transition metals
  293. Outcomes of initiation of therapy with once‐daily combination of a thiazolidinedione and a biguanide at an early stage of type 2 diabetes
  294. The inhibitory action of buformin, a biguanide on gluconeogenesis from alanine and its transport system in rat livers
  295. Antiviral activity of selected biguanide derivatives
  296. Reduced vascular events in type 2 diabetes by biguanide relative to sulfonylurea: study in a Japanese Hospital Database
  297. Circular Dichroism of Tris (biguanide) Complexes of Cobalt (III) and Chromium (III).
  298. Biguanides sensitize leukemia cells to ABT-737-induced apoptosis by inhibiting mitochondrial electron transport
  299. Relationship between tissue culture cytotoxicity and acute toxicity in mice of biguanide derivatives
  300. Comparison of the kinetic characteristics of inhibitory effects exerted by biguanides and H2-blockers on human and rat organic cation transporter-mediated transport …
  301. Role of 0.02% polyhexamethylene biguanide and 1% povidone iodine in experimental Aspergillus keratitis
  302. … properties of some five-and six-coordinate copper (II) complexes with acetylacetonate and the structural characterisation of a biguanide-acetylacetonate double salt
  303. Comparison of potential risks of lactic acidosis induction by biguanides in rats
  304. Hyperactivation of 4E-binding protein 1 as a mediator of biguanide-induced cytotoxicity during glucose deprivation
  305. … Mechanisms of Reactions of some complexes of Chromium (III). Formation of Oxalatobis (biguanide) chromium (III) Ion from Diaquobis (biguanide) chromium (III) Ion …
  306. Comparison of the in vitro effect of biguanides and sulfonylureas on insulin binding to its receptors in target cells
  307. Thermal, spectral, electrochemical and biologic characterization of new Pd (II) complexes with ligands bearing biguanide moieties
  308. Inhibition of renal sugar and amino-acid transport by n-butyl-biguanide
  309. Restricted rotation in biguanide dications
  310. Long-term effects of mitiglinide in Japanese diabetics inadequately controlled with DPP-4 inhibitor or biguanide monotherapy
  311. Kinetics of oxidation of pyruvic acid by [ethylenebis (biguanide)] silver (III) in aqueous acidic media
  312. Determination of antihyperglycemic biguanides in serum and urine using an ion‐pair solid‐phase extraction technique followed by HPLC‐UV on a …
  313. Design, synthesis, biological evaluation and toxicity studies of N,N-disubstituted biguanides as quorum sensing inhibitors
  314. Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity: the biguanides and the prevention of the risk of obesity (BIGPRO) 1 study
  315. The hyperlactatemic effect of biguanides: a comparison between phenformin and metformin during a 6-month treatment.
  316. Combined sulphonylurea-biguanide therapy for non-insulin dependent diabetics. Metabolic effects of glibenclamide and metformin or phenformin in newly diagnosed …
  317. Biguanide-induced and-associated lactic acidosis: serum and tissue biguanide levels in hyperlactaemia and lactic acidosis (author’s transl)
  318. Respiratory inhibition and hypoglycemia by biguanides and decamethylenediguanidine
  319. Contribution to the coordinative chemistry of rhodium. II. Rhodium (III) complexes with biguanide derivatives
  320. Inhibition of fatty acid oxidation by biguanides: implications for metabolic physiopathology
  321. Polyhexamethylene biguanide dressings in wound management.
  322. 1-(p-Chlorophenyl) biguanide hydrochloride, C8H11ClN5+. Cl−
  323. Effects of the biguanide synthalin A on the pancreatic A2-cell of the guinea pig
  324. L503F variant of carnitine/organic cation transporter 1 efficiently transports metformin and other biguanides
  325. Mechanisms of action of polyhexamethylene biguanide-based biocides against non-enveloped virus
  326. Blockade of the antinociception induced by diclofenac, but not of indomethacin, by sulfonylureas and biguanides
  327. Supported palladium catalysis using a biguanide N-donor motif on mesoporous silica for Suzuki-Miyaura coupling reaction
  328. Gravimetric determination of palladium with biguanide sulfate
  329. Treatment of biguanide-induced lactic acidosis: reproposal of the” physiological” approach and review of the literature.
  330. Guanidines and biguanides
  331. Thermochemical consequences of. pi. delocalization in metal-biguanide complexes
  332. Aspects of the mechanisms of action of biguanides on trophozoites and cysts of Acanthamoeba castellanii
  333. In vitro antifungal efficacy of biguanides and quaternary ammonium compounds against cleanroom fungal isolates
  334. Thermal behaviour of some iron (III) complexes with active therapeutically biguanides
  335. Binding of a Phenanthridine-Biguanide Derivative with DNA/RNA Polynucleotides Studied by Surface-Enhanced Raman Spectroscopy (SERS)
  336. Kinetics and mechanism of reactions of the ethylenebis(biguanide) silver (III) ion in aqueous perchlorate media
  337. Conversion of biguanides into substituted s‐Triazines Assayable by GC or Mass Fragmentography
  338. Experiments on Prophylaxis and Suppression of Epidemic Influenza with NSN1 Anhydrobis (β-Hydroxyethyl) biguanide Hydrochloride (ABOB). A Double Blind Study.
  339. Polyhexamethylene biguanide (0.02%) alone is not adequate for treating chronic Acanthameoba keratitis.
  340. The role of polyhexamethylene biguanide and silver nanoparticle interaction in the fabrication of novel antibacterial bio-fibers using silk wastage
  341. Effects of orthodichlorobenzene preparation and polyhexamethylene biguanide hydrochloride on activated sludge
  342. Addition of Benfluorex to Biguanide Improves Glycemic Control in Obese Non–Insulin-Dependent Diabetes: A Double-Blind Study versus Placebo
  343. Inhibiting effect of phenformin (phenethyl biguanide) on the growth of Ehrlich carcinoma
  344. Contribution to the coordination chemistry of osmium: II. Chelates of bivalent and tervalent osmium with biguanide derivatives
  345. Transport of biguanides by human organic cation transporter OCT2
  346. Voltammetric and capillary electrophoretic study of scavenger kinetics of methylglyoxal by antidiabetic biguanide drugs
  347. Crystal and molecular structure of 1-(2-aminoethyl) biguanide-isothiocyanato-copper (II) thiocyanate
  348. Effects of the 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide in the rat kindling model of epilepsy
  349. Metabolic effects of the biguanides and possible mechanism of action
  350. Binding of biguanides to β-lactoglobulin: molecular-docking and molecular dynamics simulation studies
  351. Poly (alkylene biguanides) as Proton Conductors for High‐Temperature PEMFCs
  352. Blood lactate and pyruvate levels in diabetic patients treated with biguanides with and without sulphonylureas
  353. Metformin and biguanide complexes of isothiocyanatosilane
  354. The 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide facilitates noradrenaline release by blockade of α2-adrenoceptors in the mouse brain cortex
  355. Determination of metformin and other biguanides in forensic whole blood samples by hydrophilic interaction liquid chromatography–electrospray tandem mass …
  356. The role of S‐mephenytoin hydroxylase (CYP2C19) in the metabolism of the antimalarial biguanides.
  357. Pancreatic glucagon, plasma insulin and blood glucose responses to arginine infusion in nondiabetic subjects following biguanide pretreatment
  358. Kinetic and Mechanistic Studies on the Oxidation of Nitrogen (III)(HNO2/NO_2^-) by the Tris (biguanide) manganese (IV) Ion in Aqueous Acidic Media
  359. Specific therapies of biguanide-induced lactic acidosis
  360. Crystal Data of Biguanide Dihydrochloride, C2H7N5, 2HCl
  361. Effectiveness of polyhexamethylene biguanide impregnated dressing in wound healing: a systematic review protocol
  362. Kinetics and mechanism of dissociation of bis (biguanide)‐Palladium (II) Ion in HCl NaCl Medium
  363. Kinetics and mechanism of acid-catalysed dissociation of tris (biguanide) rhodium (III) ion
  364. Effect of biguanide therapy on lactate metabolism during graded submaximal ergometric testing
  365. In vitro biological evaluation of biguanides and dihydrotriazines against Brugia malayi and folate reversal studies
  366. Spectral and Magnetic Properties of Dithiocyanato bis (Biguanide) Chromium (III) Thiocyanate
  367. Inhibition of intestinal amino acid transport by blood sugar lowering biguanides
  368. Determination of oral hypoglycemic biguanides by high performance liquid chromatography with fluorescence detection
  369. … of Optical Resolution. XI. The Crystal Structures of (+)589-Tris(biguanide)cobalt(III) Chloride d-Tartrate Trihydrate and Racemic Tris(biguanide)cobalt(III) Trichloride
  370. Metal Complexes of Amino Acids. XV. Racemization and Deuteration of Bis (biguanide) sarcosinatocobalt (III) Complex
  371. Metformin and other biguanides: pharmacology and therapeutic usage
  372. THERMAL ELECTRON TRANSFER REACTION OF SOME BIGUANIDE–COBALT (III) COMPLEXES IN SOLID PHASE
  373. Antibacterial activity of certain biguanide derivatives
  374. Mechanistic Investigation of the Oxidation of Glyoxylic and Pyruvic Acids by Tris(biguanide)manganese(IV) in Weakly Acidic Aqueous Media
  375. Preclinical pharmacology of biguanides
  376. Self-Sterilizing Materials. 1. Controlled Release of Biguanide Biocides from Polymeric Materials
  377. Inhibition of bile salt absorption by blood-sugar lowering biguanides
  378. Biguanide-induced lactic acidosis.
  379. Value of biguanide in therapy of diabetes mellitus
  380. In vitro antiplaque properties of a series of alkyl bis (biguanides)
  381. Studies on juvenile–type diabetes in children. Assessment of control under treatment with constant and variable doses of insulin with or without addition of biguanides.
  382. Regulation of the proliferation of colon cancer cells by compounds that affect glycolysis, including 3-bromopyruvate, 2-deoxyglucose and biguanides
  383. Direct effects of biguanides on glucose utilization in vitro
  384. Application of ion‐pair methods to drug extraction from biological fluids II: Quantitative determination of biguanides in biological fluids and comparison of protein …
  385. Antimalarial Activity and Metabolism of Biguanides. I. Metabolism of Chlorguanide and Chlorguanide Triazine in Rhesus Monkeys and Man.
  386. The phenanthridine biguanides efficiently differentiate between dGdC, dAdT and rArU sequences by two independent, sensitive spectroscopic methods
  387. Injury and recovery of Escherichia coli ATCC 8739 from treatment with some polyhexamethylene biguanides.
  388. Quantitation of polyhexamethylene biguanide by photometric titration with Naphthol Blue Black dye
  389. Antitumor properties of boron complexes with hydroxy biguanide and salicyl hydroxamic acid against Ehrlich ascites carcinoma.
  390. Clinical pharmacology of biguanides
  391. Antimalarial compounds. X. Biguanide and amidinourea derivatives of diphenyl sulfide, sulfoxide, and sulfone
  392. Insufficient correction of blood bicarbonate levels in biguanide lactic acidosis treated with CVVH and bicarbonate replacement fluids
  393. Synthesis, characterization, and biodistribution of oxo complexes of Technetium-99m with biguanide and N1-substituted ligands
  394. Interactions of ethanol with nicotine, dizocilpine, CGP 40116, and 1-(m-chlorophenyl)-biguanide in rats
  395. Effect of N1, N1-anhydrobis-(β-hydroxyethyl) biguanide hydrochloride (ABOB) against adenovirus
  396. The effect of N1, N1-anhydrobis-(β-hydroxyethyl) biguanide hydrochloride against the growth of Sendai virus in HeLa cell cultures
  397. Electron‐microscopic study of the bactericidal effect of OPB‐2045, a new mono‐biguanide disinfectant produced from biguanide group compounds, against …
  398. Kinetics and Mechanism of Oxidation of Fe2+ by the Tris(biguanide)manganese(IV) Ion in Aqueous Acid Media
  399. Assessment of antimicrobial activity of novel disinfectant based on peroxygen/biguanide/alcohol combination
  400. Effects of the biguanide metformin on splanchnic blood flow in rats: preferential and dose-dependent increase in islet blood flow
  401. Breast cancer inhibition by a novel and potent biguanide, N1-hexyl-N5-benzyl-biguanide
  402. Comparison of gene expression changes induced by biguanides in db/db mice liver
  403. CLINICAL EVALUATION OF N1N1ANHYDROBIS (βHYDROXYETHYL) BIGUANIDE HYDROCHLORIDE IN THE TREAT MENT OF PHARYNGOCONJUNCTIVAL …
  404. Application of ion-pair methods to drug extraction from biological fluids I: quantitative determination of biguanides in urine
  405. Effects of 2, 4-Dimethoxyphenyl Biguanide on Glutathione System Activity in Rat Tissues in Brain Ischemia–Reperfusion
  406. O-Tolyl Biguanide Complexes of Some Transition Metal Ions in 1-Methyl-2-Pyrrolidinone
  407. The importance of lactate acidosis as a side effect of biguanide therapy
  408. Anti-diabetic biguanides inhibit hormone-induced intracellular Ca2+ concentration oscillations in rat hepatocytes
  409. Effect of Zn2+ on the Proteolytic Inhibitory Action of Insulin and Biguanide Antihyperglycemic Drugs
  410. Characterization of biguanides by 15N NMR spectroscopy
  411. Effect of biguanides and atromid on fibrinolysis
  412. Kinetics and mechanism of the oxidation of oxalic acid and bioxalate ion by [ethylenebis(biguanide)] silver (III) cation in aqueous perchlorate media
  413. Interaction of Biguanides with Mitochondrial and Synthetic Membranes: Effects on Ion Conductance of Mitochondrial Membranes and Electrical Properties of …
  414. Inhibitory and lethal effects of chlorhexidine and a polymeric biguanide on some strains of Providencia stuartii
  415. Discrimination of ethanol in rats: effects of nicotine, diazepam, CGP 40116, and 1-(m-chlorophenyl)-biguanide
  416. Clinical Efficacy of Polyhexamethylene Biguanide Lid Scrub on Demodex Blepharitis.
  417. Quantitative structure-activity relationships for biguanides, carbamimidates, and bisbiguanides as inhibitors of Streptococcus mutans No. 6715
  418. The effect of the disulfideisomerase domain containing protein in the defense against polyhexamethylene biguanide of highly tolerant Acanthamoeba at the …
  419. The 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide interacts with the dopamine transporter in rat brain synaptosomes
  420. Biguanides may produce hypoglycemic action in isolated rat hepatocytes through their effects on L-alanine transport
  421. Prediction of 99mtc-biguanide complex structures and their interactions with biological molecules by molecular mechanics calculations
  422. Reactions of alkylbiguanides with benzoin at thepH of the biguanide bases
  423. Difference between biguanide and thiazolidinedione, and the significance of combination therapy of biguanide and thiazolidinedione
  424. 5-HT3 receptors in NG108-15 neuroblastoma× glioma cells: effect of the novel agonist 1-(m-chlorophenyl)-biguanide
  425. Lactic acidosis, diabetes mellitus and the biguanide compounds
  426. Short-term effect of buformin, a biguanide, on insulin sensitivity, soluble fraction of tumor necrosis factor receptor and serum lipids in overweight patients with type 2 …
  427. 99m Tc-labelled biguanide derivatives: chemical speciation modelling thereof and evaluation in vervets
  428. Mutagenic effect of 1.1′-hexamethylene-bis-[(5-p-chlorophenyl)-biguanide]
  429. Reactivity of 1, 3-diaryl-2, 4-bis (heteroarylimino)-1, 3-diazetidines. Formation of N1, N2, N3, N4, N5-pentasubstituted biguanides
  430. Interaction of Biguanides with Mitochondrial and Synthetic Membranes: The Role of Phospholipids as Natural Binding Sites
  431. Interaction of biguanides with mitochondrial and synthetic membranes
  432. Clinical trial of 0.02% polyhexamethylene biguanide versus placebo in the treatment of microsporidial keratoconjunctivitis
  433. A Clinical Evaluation ofN1, N1-Anhydrobis-(β-R ydroxyethyl) Biguanide-Hydrochloride (ABOB) in the Treatment of Acute Respiratory Infections: a Double-Blind Study.
  434. Effects of 1, 1′-hexamethylene-bis-[(5-p-chlorophenyl)-biguanide] on the genome and on the synthesis of nucleic acids and proteins in the bacterial cells
  435. Acid dissociation constants of [ethylenebis (biguanide) silver (III) cation in aqueous perchlorate media
  436. Structural Study of Optical Resolution. IX. The Crystal Structure of (−)589-Tris(biguanide)cobalt(III) Chloride d-Tartrate Pentahydrate
  437. Use of biguanides and the risk of colorectal cancer: a register-based cohort study
  438. Electron-microscopic study of the bactericidal effect of OPB-2045, a new disinfectant produced from biguanide group compounds, against methicillin-resistant …
  439. The effect of mouthwashes containing biguanides on the progression of erosion in dentin
  440. Evaluation in the baboon model of 99mTc-biguanide as a tracer for renal imaging
  441. Silver (I) and silver (III) complexes of biguanides and N′-amidinoisoureas
  442. SCCS opinion on polyaminopropyl biguanide (PHMB)-submission III
  443. The effect of polyhexamethylen biguanide on microorganisms in root canal/Utjecaj poliheksametilenova bigvanida na mikroorganizme u korijenskom kanalu zuba
  444. Metformin as an anticancer drug: a commentary on the metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
  445. The Determination of Biguanide
  446. Liver uptake of Biguanides in rats
  447. Crystal structure of 1-(m-chlorophenyl) biguanide hydrochloride
  448. The Prophylactic Effect of N1, N1-Anhydrobis (β-Hydroxyethyl)-N5-(p-Toluenesulfonyl) Biguanide on Poliovirus Infection in Mice
  449. Crystal structural studies of bis (biguanide) nickel (II) chloride
  450. Polarographic Studies of Cobalt (III) Complexes with Biguanide & Substituted Biguanides
  451. Effects of biguanides and sulfonylureas on insulin receptors in cultured cells.
  452. Reactions of arylbiguanides with benzoin at thepH of the biguanide bases
  453. In Vitro Amoebicidal Efficacy of Hexamidine, Polyexamethylene Biguanide and Chlorhexidine on Acanthamoeba Ccular Isolates
  454. Biguanide Treatment in Diabetes Mellitus: A Short Review
  455. Decomposition kinetics ofbis(biguanide)silver(III) cation in acid perchlorate media
  456. A Triply Hydrogen-Bonding System Constructed by Self-Assembly of Biguanide Complex and Imide-Containing Compound
  457. Mechanistic studies on six-membered chelate complexes. Aquation of some dichlorobis (substituted biguanide) rhodium (III) nitrates
  458. UK Prospective Diabetes Study: II. Reduction in HbA1c with Basal Insulin Supplement, Sulfonylurea, or Biguanide Therapy in Maturity-onset Diabetes
  459. The effect of some bis-biguanides on experimental dental caries in the hamster
  460. Synthesis and effect of biguanide derivatives on biochemiluminescence and level of reduced glutathione in rat blood serum and brain under ischemia-reperfusion …
  461. The Mechanism for the Reaction of Biguanides with Diethyl Oxalate
  462. Synthesis and structure of the first water-soluble chiral monomeric MnIV complex: [Δ-MnIV(biguanide)3] (ClO4)4·H2O
  463. Effects of biguanides on fatty acid and glucose oxidation in muscle
  464. Reaction of biguanides and related compounds. XVI. Synthesis of s‐triazinones and fused s‐triazinones by carbonylation of biguanides and related compounds with …
  465. Reaction of biguanides and related compounds. XV. Cyclizations of arylbiguanides and 2-guanidinobenzimidazole with bifunctional unsaturated dicarboxylates to s …
  466. Reactions of secondary silanes with biguanide bases: synthesis and characterization of oligomeric 1, 4-bis (silyl) biguanides and 1-alkyl-2, 5-bis (silyl) biguanides
  467. A study of the antibacterial activity of polyhexamethylene biguanide on cotton substrate
  468. Chemotherapy of malaria: III. Attempted synthesis of biguanide and guanidino derivatives of quinoline
  469. Effect of biguanides on the respiration of tumour cells
  470. Hydrogen-bonded networks in crystals built from bis (biguanides) and their salts
  471. Ag electrode modified with polyhexamethylene biguanide stabilized silver nanoparticles: a new type of SERS substrates for detection of enzymatically generated …
  472. The association between the biguanide drug metformin and vitamin B12 deficiency in diabetic patients: a systematic review
  473. Improving management of type 2 diabetes mellitus: 2. Biguanides
  474. The antidiabetic biguanide metformin induces growth arrest in multiple myeloma cells in vitro, overcoming the effect of stromal cells
  475. The Antimicrobial Activity of N1, N5-Substituted Biguanides.
  476. Mechanistic studies on the Reactions of Cis‐Diaquobis (Biguanide) Chromium (III) ion with 2, 2′‐dipyridyl and 1, 10‐phenanthroline
  477. Cervicovaginal safety of the formulated, biguanide-based human immunodeficiency virus type 1 (HIV-1) inhibitor NB325 in a murine model
  478. Biguanides and lactic acidosis.
  479. Studies of Chemical Inhibitors of Influenza Virus Multiplication: I. Biguanides and Related Compounds.
  480. Kinetics and mechanism of dissociation of copper(II) complexes of biguanide and someN 1-substituted biguanides in aqueous acetate buffer media
  481. Complex formation followed by internal electron transfer: the reaction of [ethylenebis (biguanide)] silver (III) with ascorbic acid
  482. Survival of community-associated methicillin-resistant Staphylococcus aureus in 3 different swimming pool environments (chlorinated, saltwater, and biguanide …
  483. Comparison of the Quality of Life of Type 2 Diabetes Mellitus Patients Treated with Biguanides, Thiazolidinediones and Sulphonyl ureas
  484. The risk of lacticate acidosis: a comparison of the 3 biguanides in treatment of diabetics (authors’ transl)
  485. Evaluation of Efficacy of Polygexamethylene biguanide in Experimental Pseudomonas aeruginosa Keratitis
  486. Kinetics and mechanism of reactions of bis(biguanide)copper(II) ion with glycine and α-alanine in aqueous media
  487. Mechanistic studies on the oxidation of hydrazine by tris (biguanide) manganese (IV) in aqueous acidic media
  488. In vitro sensitivity testing of acanthamoeba clinical isolates from patients with keratitis against polyhexamethylene biguanide (PHMB) and chlorhexidine
  489. … directs the self-assembly of a transition metal complex: Synthesis and structural characterization of cis-dichloro [1-(2-aminoethyl) biguanide] copper (II) monohydrate
  490. Kinetics of substitution of aquo ligands fromcis-diaquo-bis-(biguanide) cobalt(III) and chromium(III) ions by aspartic acid in ethanol—water mixtures
  491. Lactic acidosis in diabetics on biguanides (author’s transl)
  492. … of buformin hydrochloride, phenformin hydrochloride and phenylbiguanide: The pyrolytic formation of substituted 2, 4, 6-triamino-1, 3, 5-triazines form biguanides
  493. A direct access to heptasubstituted biguanides
  494. Antifertility effects of biguanides.
  495. Effects of biguanides on the intermediate metabolism of glucose in normal and portal-strictured rats.
  496. Studies on the Aqueous Solutions of Guanidinium Salts. IX. Activity Coefficients of Biguanide Hydrochloride and Sucrose in Aqueous Ternary Solutions at 25° C
  497. Some Substituted Biguanides and s-Triazines1
  498. Kinetics and mechanism of reactions of bis (biguanide) copper (II) ion with 2, 2′-bipyridyl and 1, 10-phenanthroline in aqueous solution
  499. BIGPRO (biguanides and the prevention of the risk of obesity): study design. A randomized trial of metformin versus placebo in the correction of the metabolic …
  500. Determination of N′, N′-anhydrobis (β-hydroxyethyl)-biguanide hydrochloride in urine
  501. Structure of mono-, di-, and tri-protonated biguanides
  502. Silver (III) biguanides
  503. Identification of two kinds of biguanides illegally added to traditional Chinese medicines and health products by TLC-IR
  504. Use of biguanide sulphate as a reagent
  505. Inhibition of Na+-K+-Dependent ATP-ase from Mucosa of Human Small Intestine by Butyl-Biguanide
  506. Chemistry and structure-activity relationships of biguanides
  507. Fluorometric determination of biguanides in serum by high-performance liquid chromatography with reagent-containing mobile phase
  508. Substitution reaction of aquo ligands from cis-diaquo-bis (biguanide)-chromium (III) ion with picolinic acid in aqueous medium: Kinetics and mechanism
  509. Prospects of use of antidiabetic biguanides for cancer prevention and treatment: Results of preclinical studies
  510. Kinetic & Mechanistic Studies on Substitution Reactions of Aquo-ligands from cis-Diaquo-bis (biguanide) cobalt (III) Ion with β-Phenylalanine in Aqueous …
  511. … of Acid-catalysed Dissociation of Unsymmetrical Chelate Complex of Cobalt (III): Acid-catalyzed Aquation of Picolinatobis (biguanide) cobalt (III) Perchlorate
  512. CytochromeP450 isoenzyme specificity in the metabolism of anti-malarial biguanides: molecular docking and molecular dynamics analyses
  513. The activity of triple combinations of antifolate biguanides, with and without folinic acid, against Plasmodium falciparum in vitro
  514. Four cases of fatal lactic acidosis during biguanide therapy (author’s transl)
  515. Microbiological activity of some 3d and 4f metal complex compounds with N-substituted biguanide
  516. The effects of diabetes mellitus, exercise, and single doses of biguanides upon lactate metabolism in man.
  517. … of McN-3495 [N-(1-methyl-2-pyrrolidinylidene-N’ -phenyl-1-pyrrolidinecarboximidamide], A New, Orally Effective, Hypoglycemic Agent, with the Biguanides
  518. The Effect of Polyhexamethylen Biguanide on Microorganisms in Root Canal
  519. Further studies on the antiviral effect of some biguanide derivatives.
  520. Higher valent manganese chemistry.[Mn (biguanide) 3]+, a structurally characterized Mn IV complex with all-nitrogen coordination
  521. Pharmacology of certain antimicrobial N1, N5-substituted biguanides
  522. Glutathione system activity in rat tissues under phenylethyl biguanide action on the background of experimental brain ischemia/reperfusion development
  523. A new use of polymeric biguanide as an antimicrobial agent on cellulosics
  524. Co-ordination compounds of iridium (III) with biguanide
  525. Reaction of Biguanides and Related Compounds. XIII. Benzilic Acid Rearrangement. The Reactions of 1, 2-Cyclohexanedione and 9, 10-Phenanthrenequinone with …
  526. Contribution to the coordination chemistry of molybdenum (V) EPR study of some Mo (V) oxycompounds with biguanide derivatives
  527. Evaluation of teat-dipping formulations containing a germicidal polymeric biguanide.
  528. The design and synthesis of vanadyl-biguanide complexes as potential synergistic insulin mimics
  529. Antidiabetic behavior of biguanides
  530. Reaction of Biguanides and Related Compounds. I. Reaction of Biguanides with β-Diketone
  531. Biguanides and targeted anti-cancer treatments
  532. Potentiometric determination of n-butyl-1-biguanide with a liquid-state Cu2+-sensitive electrode
  533. Chelation of β‐phenethylbiguanide and other biguanides with copper ion
  534. HPLC/MS2 detection of biguanides and sulfonylurea antidiabetics illegally mixed into traditional Chinese preparations
  535. Biguanides: reasons for withdrawal of drugs and remaining indications
  536. Increased alanine uptake and lipid synthesis from alanine in isolated hepatocytes of Wistar-Kyoto fatty rats: an inhibitory effect of biguanides
  537. … OF THE FIBRINOLYSIN SYSTEM OF THE RAT. III. THE MECHANISM OF PHENFORMIN [1-(β-PHENETHYL)-BIGUANIDE]-INDUCED FIBRINOLYTIC ACTIVITY
  538. Biguanides Part 1. The thermal decomposition and mass spectral behaviour of biguanide and some of its salts
  539. Reaction of Guanidines with α-Diketones. VI. Structures of Fluorescent Products of Biguanides with 9, 10-Phenanthraquinone
  540. Molecular structure of 1-(2-sulfoethyl) biguanide
  541. Reaction of Biguanides and Related Compounds. X. The Cyclization of Arylbiguanides with Acyl Isothiocyanates
  542. Reaction of Biguanides and Related Compounds. VIII. The Condensation of Arylbiguanides and N-Amidino-O-alkylisoureas with Diketene and Ethyl Acetoacetate
  543. Reaction of biguanides and related compounds. II. Reaction of biguanides with benzil
  544. Kinetics & Mechanism of Chelate Formation-Reaction between cis-Diaquobis (biguanide) cobalt (III) Ion & Biguanide in Aqueous Solution
  545. KINETIC AND MECHANISTIC STUDY ON THE SUBSTITUTION REACTION OF AQUO-LIGANDS FROM CIS-DIAQUO-BIS (BIGUANIDE) CHROMIUM (III) ION WITH …
  546. Cu (II) and Zn (II) complex compounds with biguanides aromatic derivatives. Synthesis, characterization, biological activity
  547. The Efficacy of Polyhexamethylene Biguanide on Experimental Staphylococcus Aureus Keratitis
  548. Inhibition of ethanol absorption by butyl-biguanide in rat gastrointestinal tract in vivo
  549. Modulation of cardiomyocyte and hepatocyte bioenergetics by biguanides
  550. Polyhexamethylene biguanide in vaginal solution is effective in the treatment of vulvovaginal candidiasis: a pilot study
  551. Preliminary antimalarial screening tests of some biguanide derivatives
  552. A new in vivo model for the study of potential fibrinolytic agents. I. Action of the biguanide phenformin
  553. Reaction of Biguanides and Related Compounds. III. Reaction of Biguanide and Amidinoisourea with Oxamate
  554. Pharmaceutical cocrystals of the biguanide drug Metformin
  555. Complex compounds of some N′‐alkyl‐biguanides with metallic elements
  556. Biguanides and gastric emptying in man
  557. Polarographic Behaviour of Nickel (II) Complexes with π Basic Ligands (Biguanides & N’-Amidinoisoureas)
  558. Evaluating the efficacy of polyhexamethylene biguanide at suppressing Salmonella typhimurium in the water column of red-eared slider turtles, Trachemys scripta …
  559. Reaction of Biguanides and Related Compounds. XII. Condensations of Arylbiguanides and Amidinoisoureas with Isatins
  560. Endothelial Effects of Sulfonurea and Biguanide Therapy in Type 2 Diabetes Mellitus
  561. Reaction of Biguanides and Related Compounds. IX. Condensation of N-Amidino-O-alkylisourea and 1-substituted 3-Amidino-2-thiourea with Benzil
  562. Phenyl biguanide does not inhibit locomotion in conscious rabbits
  563. The uses of biguanides in diabetes mellitus.
  564. Tissue culture studies of the inhibition of Lee influenza virus by isopropyl biguanide
  565. Modelling of the blood plasma species of biguanide derivatives exhibiting potential as diagnostic radiopharmaceuticals
  566. Evidence summary: Polyhexamethylene biguanide (PHMB) wound dressings
  567. Blood lactate and biguanide therapy: comparison between phenformin, metformin and buformin in 408 senile diabetics
  568. A new class of cytostatic folic acid antagonists 1-(3, 4-Dichlorophenyl)-5-isopropyl-biguanide and its boron compounds
  569. Biguanides in the treatment of diabetes mellitus
  570. A new in-vivo model for the study of potential fibrinolytic agents. II. Screening of candidate biguanide analogues and other organic compounds
  571. Importance of Mn++ in the regulation of gluconeogenesis in cellular and acellular kidney cortex systems: new data on mechanism of action of biguanides
  572. Transition metal complexes of amidinourea and related ligands, part 3. Mixed ligand complexes of cobalt (III) containing biguanide, O-methyl-l-amidinourea and some …
  573. Reaction of Biguanides and Related Compounds. XIV. Cyclization of Amidinothioureas with Some Carbonyl Compounds
  574. Reaction of guanidines with alpha-diketones. IV. The reactivity of guanidine, monosubstituted guanidines, and biguanides and the fluorometric determination of …
  575. KINETICS AND MECHANISM OF DISSOCIATION OF SOME BIS-(N1-SUBSTITUTED BIGUANIDE) COMPLEXES OF NICKEL(II) IN AQUEOUS ACID
  576. EPR Study of some Copper (II) Coordination Compounds with substituted Biguanides. III
  577. Mechanism of reactions of some N 1-substituted biguanides with chromium (VI) in aqueous sulphuric acid media
  578. Inter-individual variation in the metabolic activation of the antimalarial biguanides
  579. … and pharmacodynamic approach to identify opportunities and pitfalls in energy stress-mediated chemoprevention: the use of metformin and other biguanides
  580. Targeting apoptosis, advanced glycation end products and transforming growth factor-β1 by biguanides and resveratrol to ameliorate experimentally-induced …
  581. Biguanides and lactic acidosis in diabetics.
  582. Miltefosine and polyhexamethylene biguanide, a new drug combination for the treatment of Acanthamoeba keratitis. Results from in‐vivo toxicological and efficacy …
  583. Ferric complexes with biguanides in the spin quartet ground state
  584. Biguanide therapy for diabetes and cancer & a novel methyltransferase that regulates energy expenditure and adiposity and is elevated in many cancers
  585. Novel pentacoordinate silicon compounds bearing [Si-NCNCN] chelate ring derived from biguanide ligands
  586. Kinetic & Mechanistic Studies on Substitution Reaction of Aquo-ligands from cis-Diaquo-bis (biguanide) cobalt (III)/chromium (III) Ions in Aqueous Medium
  587. Reaction of Biguanides and Related Compounds. V. The Base-catalyzed Condensation of Benzil with 1, 1-Dialkylguanidine
  588. Bactericidal Activity and Physiological Effects of Combined Application of Poly-Hexamethylene Biguanide Hydrochloride and 1-bromo-3-chloro-5, 5 …
  589. Kinetics and mechanism of the displacement of aqua ligands from cis-diaqua-bis(biguanide)chromium(III) by pyridine-2-aldoxime in EtOH-H2O mixtures
  590. concentration of polyhexamethylene biguanide
  591. Kinetics and mechanisms of the reactions of unsymmetrical chelate complexes. Acid-catalyzed aquation of glycinatobis-(biguanide) cobalt (III) perchlorate
  592. Use of biguanides to improve response to chemotherapy
  593. In vitro activity of N’, N’-anhydrobis (β-hydroxyethyl) biguanide hydrochloride (ABOB) against parainfluenza viruses.
  594. Biguanides and lactic acidosis in diabetics
  595. Biguanide Derivatives of γ-Pyridones
  596. Diuretics on the basis of N-substituted 2, 4-diamino-s-triazines by cyclisation of biguanides (author’s transl)
  597. Analyses of biguanides and related compounds in biological and environmental samples by HPLC
  598. Effect of biguanides on the peripheral oxidation of glucose
  599. CIRCULAR DICHROISM OF COBALT(III) COMPLEXES OF THE TYPE[Co(N)6] CONTAINING BIGUANIDE, AND 2,2′-DIPYRIDYL OR 1,10-PHENANTHROLINE
  600. Substitution of aqua ligands from cis-diaqua-bis(biguanide) chromium(IIT) by glutamic acid in various ethanol-water mixtures – A kinetic study
  601. Physicochemical properties and analytical methods of determination of biguanides
  602. Effects of biguanides on short-circuit current in frog skin
  603. Toxicity of Amphoteric Surfactant, Biguanide Compounds and Orthodichlorobenzene Preparation against Ciliate Colpoda aspera
  604. Therapeutic utility of biguanides in the treatment of NIDDM
  605. Kinetics of oxidation of ethanol, isopropyl alcohol, and benzyl alcohol by [ethylenebis (biguanide)] silver (III) cation in aqueous perchloric acid solutions
  606. Effects of biguanides on gluconeogenesis in rats and guinea pigs
  607. THE USE OF NEGATIVE WOUND PRESSURE THERAPY AND POLYHEXAMETHALENE BIGUANIDE IMPREGNATED GAUZE TO PROMOTE WOUND HEALING …
  608. Reaction of Biguanides and Related Compounds. VI. Condensation of N-Amidino-O-alkylisourea with β-Diketone
  609. Biguanide-Atovaquone Synergy against
  610. Reaction of biguanides and related compounds. VII. The condensation of arylbiguanide with α, β-unsaturated carboxylic ester in dimethylformamide
  611. Crystal spectrum of copper biguanides
  612. Mechanism of action of biguanides, with special reference to phenethylbiguanide, in the human being
  613. Reaction of Biguanides and Related Compounds. IV. Reaction of Arylbiguanide with Benzoylacetone in the Presence of a Small Amount of the Arylbiguanide …
  614. The reaction of the mutagen 1, 1′-hexamethylene-bis [(5-p-chlorophenyl)-biguanide] with guanosine and cysteine
  615. The effect of biguanide preparations on lipid metabolism
  616. Electrophilic substitution on metal biguanides and metal amidinoureas
  617. Biguanides and the metabolic responses to exercise
  618. Reduction of SSI’s Using a 0.2% Polyhexamethylene Biguanide Impregnated Island Dressing, Placed in the Sterile OR Setting, Versus Non-Impregnated Island …
  619. Reaction of Biguanides and Related Compounds. IX. Condensation of N-Amidino-O-alkylisourea and 1-Substituted 3-Amidino-2-thiourea with Benzil
  620. Reaction of guanidines with. ALPHA.-diketones. VI. Structures of fluorescent products of biguanides with 9, 10-phenanthraquinone.
  621. Biguanides in the treatment of type II diabetes
  622. Results of long-term biguanide therapy as a preventive measure in protodiabetes
  623. Panic attack caused by biguanides
  624. Cocaine Interactions with Serotonin 5-HT~ 3 and Dopamine Receptors: Studies of the 5-HT~ 3 Agonist 1-(META-Chlorophenyl)-Biguanide (mCPB) as a …
  625. The experience of using biguanide siofor with polycystic ovary
  626. Activity of Certain Aryl–Substituted Biguanides as Accelerators of Vulcanization1,2
  627. Indications and contraindications of biguanide therapy in diabetes mellitus
  628. Mixed Ligand Complexes of Pt (II) with Biguanide & Triphenylphosphine
  629. Use of biguanide preparations in the treatment of diabetes mellitus
  630. Reaction of 1-Substituted Biguanide with Diethyl Formylsuccinate and Diethyl Succinate.
  631. Diabetic hearts and biguanides.
  632. Short-term Effect of Buformin, a Biguanide, on Insulin Sensitivity with IGT or NIDDM
  633. S-triazines: V. Synthesis of fluoroalkylguanamines by reaction of fluoroolefins with biguanide
  634. agent which is not sulfonylurea but biguanide
  635. Evaluating a dressing impregnated with polyhexamethylene biguanide
  636. Role of carnitine in promoting the effect of antidiabetic biguanides on hepatic ketogenesis
  637. Studies of some transition metal complexes of biguanide and related ligands
  638. Solvent extraction of some metal ions using a biguanide complexant
  639. Lactacidosis in biguanide therapy: diagnosis and therapy. 4 cases compared to 179 cases in the world literature
  640. A study of some biguanide complexes of rhenium (V)
  641. Determination of Nickel with Biguanide. AK Majumdar (J. Indian Chen?. Soc., 1943, 20
  642. Phosphinylguanidines. Phosphorus Analogs of Biguanides
  643. BIOLOGICAL ACTIVITY OF SOME NEW Ln (III) COMPLEX COMPOUNDS BASED ON BIGUANIDE DERIVATIVES
  644. The pharmacological blockade of protein glycosylation in diabetes mellitus using sulfonylurea derivatives and biguanides
  645. Determination of proguanil, cycloguanil and 4-chlorophenyl-biguanide in saliva and plasma by ion-pairing column switching HPLC
  646. Role of metabolic rehabilitation-based approach in TNBC: biguanide metformin and more
  647. SYNTHETIC ANTIMALARIALS: SOME BIGUANIDE DERIVATIVES OF ALPHA-ALKYL AMINO-ORTHO CRESOLS.
  648. Antiferromagnetic Interaction in Mn (IV) Biguanide Complexes
  649. SYNTHESIS OF SOME BIGUANIDE AND AMIDINEUREA DERIVATIVES OF QUINOLINE.
  650. Response of escherichia coli to the biocide polyhexamethylene biguanide
  651. Syntheses of Substituted Guanyl-O-Alkylisoureas, N1, N5-Disubstituted Biguanides and Substituted Guanyl Urethanes
  652. SOME APPLICATIONS OF HPLC IN THE STUDY OF BIGUANIDE ANTIMALARIAL DRUGS.
  653. Effect of biguanide on excystment, proliferation and death of Acanthamoeba strains
  654. Coordination equilibria of mixed ligand complexes of Cuˡˡ with glycylglycine and biguanide
  655. Synthesis and purification of carbon‐14 labelled 1, 1‐hexamethylene‐bis [5‐(4‐chlorophenyl) biguanide](chlorhexidine),’Hibitane’
  656. Interaction of a Biguanide Compound with Membrane Model Interface Systems: Probing the Properties of Antimalaria and Antidiabetic Compounds
  657. EFFECT OF TREATMENT OF DRINKING WATER WITH POLYMERIC BIGUANIDE (VANTOCIL IB) UPON THE REDEMPTION AND SANITY OF BROILERS
  658. Effect Of Polyhexamethylene Biguanide On Human Corneal Epithelial Barrier Function
  659. Failure of the Biguanide Moroxydine Chloride to Stimulate Plasma Fibrinolytic Activity
  660. Comparative Analysis of In Vitro Biocompatibility Assays of Polyhexamethylene Biguanide Disinfecting Contact Lens Multi-Purpose Solutions
  661. Guanyl-ο-Alkylisourea. III Synthesis of Mono Substituted Biguanide by Reaction of Mono Amine with Guanyl-ο-Alkylisourea Salt.
  662. A Comparative Study of the Effect of Hydrogen Peroxide and Polyhexamethylene Biguanide Contact Lens Solutions on Pseudomonas aeruginosa, in vitro.
  663. Keywords: Kinetics, copper (II), biguanide, amino acids, associative mechanism
  664. The effect of biguanides on insulin sensitivity of maturity onset diabetics (author’s transl)
  665. Antiviral Properties of Polymeric Aziridine-and Biguanide-Modified Core–Shell Magnetic Nanoparticles
  666. Effectiveness of N’, N’-anhydrobis (β-hydroxyethyl) biguanide hydrochloride (ABOB) in the treatment of pharyngoconjunctival fever.
  667. Effects of o-dichlorobenzene preparation and polyhexamethylene biguanide hydrochloride on activated sludge
  668. Effects of polyhexamethylene biguanide and chlorhexidine on four species of Acanthamoeba in vitro
  669. Clinical Outcomes in Acanthamoeba Keratitis Treated with Polyhexamethylene Biguanide as Monotherapy
  670. Comparative performance of analytical techniques for polyhexamethylene biguanide (PHMB) in ophthalmic solutions
  671. Circular Dichroism of Mixed Biguanide Ethylenediamine Cobalt (III) Complexes
  672. Clinical difference between thiazolidinediones and biguanides
  673. Eye-symptoms in a case of lactate acidosis caused by Biguanide-therapy (author’s transl)
  674. EFFECT OF TREATED WATER WITH POLYMERIC BIGUANIDE (VANTOCIL IB), UPON THE ERITHROCYTE PARAMETERS AND TOTAL PLASMA PROTEINS OF …
  675. Research Oxygen consumption is depressed in patients with lactic acidosis due to biguanide intoxication
  676. Sur la Formation des 8-Triazines par Action de Biguanides sur l’Ethoxymethylene Acetoacetate d’Ethyle ou sur l’Ethoxymethylene Malonate d’Ethyle
  677. Histopathological assessment of side effects of the use of corneal intrastromal biguanide in rabbits
  678. Biologically active complex compounds of biguanide derivatives with 3d and 4f metals
  679. Galvanostatic Polarisation & Temperature Kinetic Studies of Acid Corrosion of Low Carbon Steel in Sulphuric Acid in Presence of Biguanide
  680. The Effect of Urea, Biguanide and Oxazine Derivatives on the Development of Protozoa.
  681. The Role of Polyhexamethylene Biguanide and Silver Nanoparticle Interaction in the Fabrication of Novel Antibacterial Bio-Fibers Using
  682. Screening of some Biguanide Derivatives tor Antimalarial Activity.
  683. Curing of liquid crystalline epoxy resins with a biguanide
  684. Studies on the SiH/NH dehydrocoupling reactions of secondary/primary organosilanes and carbosilanes with biguanide ligands-synthesis, characterization and …
  685. Inhibiting stemness and invasion property of glioblastoma tumorsphere by a newly designed biguanide
  686. Kinetics of silver (I)-catalysed oxidation of hydrazinium ion by the [ethylenebis (biguanide)] silver (III) cation
  687. Is Polyhexamethylene Biguanide (PHMB) an Effective Disinfectant for Adenovirus?
  688. The effect of oral butyl-biguanide on oral glucose tolerance and renal glucose reabsorption in normal human subjects in vivo (author’s transl)
  689. Pharmaceutical cocrystals of biguanide drugs: Metformin case study
  690. ANTIBACTERIAL ACTIVITY AND QUANTIFICATION OF POLYHEXAMETHTYLENE BIGUANIDE HYDROCHLORIDE IN MUSCULAR TISSUES AND VISCERA OF …
  691. The Effects of Biguanides on Thrombokinase, Thrombin and Trypsin
  692. Kinetics and Mechanism of the Reactions of Bis (biguanide) copper (II) Ion with Different Amino Acids in Aqueous Media
  693. Aquation of cis-dichlorobis (biguanide) ruthenium (III) chloride in aqueous-organic solvent
  694. Effects of polyhexamethylene guanidine-phosphate and polyhexamethylene biguanide on epithelial-mesenchymal transtion in A549 cell line
  695. Does atorvastatin work more effectively than biguanides in reducing cardiovascular risk factors?
  696. Effect of biguanide derivatives on the indicators of lipid metabolism and the functional state of blood mononuclear cells in patients with insulin-dependent diabetes …
  697. Study of Polyhexamethylene Biguanide and Calcineurin Inhibitors for the Treatment of Aspergillus Keratitis in a Murine Model
  698. Kinetics and mechanism of anation of cis-diaquo-bis(biguanide) chromium(III) ion by β-phenylalanine in aqueous medium
  699. Correction of endocrine-metabolic disorders in oncologic patients. The effect of biguanides (phenformin and adebita), miskleron and diphenin
  700. Mechanism of ring closure of aryl biguanide derivatives to isoammelines: Benzylation of dicyandiamide
  701. An Appraisal of 1, 1-dimethyl-biguanide Treatment for Diabetics Based on Changes in Blood Lactate Levels
  702. Development and validation of an analytical method for determination of polyhexamethylene biguanide level in the presence of quaternary ammonium …
  703. Comparative evaluation of efficacy of Herbal extract, Bis-biguanide and Povidone-iodine containing mouthwash A clinico-microbiological study
  704. THE EFFECTS OF THIAZOLIDINEDIONE AND BIGUANIDE COMBINATION THERAPY ON SERUM LIPID CONCENTRATIONS AND GLYCEMIC CONTROL IN …
  705. Removal of Cu2+ from aqueous solution by biguanide-Functionalized Magnetic Mesoporous Silica
  706. Virobis (N1 N1 Anhydrobis (Beta-hydroxyethyl) biguanide hydrochloride) in chicken-pox
  707. Severe hypoglycemia caused by Sulfonylureas and Biguanides in a patient with obstructive anuria: Resolution with ureteral stent
  708. Studies on the Aqueous Solutions of Guanidinium Salts. X. Activity Coefficients of Biguanide Salts in Aqueous Solutions at 25° C
  709. Studies on the Aqueous Solutions of Guanidinium Salts. X. Activity Coefficients of Biguanide Salts in Aqueous Solutions at 25° C
  710. Effect of bed time intermediate acting insulin in NIDDM subjects refractory to a combination of sulphonylureas and biguanides.
  711. Kinetics of the uncatalysed and silver (I)-catalysed oxidation of hydrogen peroxide by [ethylenebis (biguanide)] silver (III) ion in acid perchlorate media
  712. Effects of biguanides on oxidative status of rat tissues after cerebral ischemia/reperfusion
  713. THE REACTION OF BIGUANIDE WITH ESTERS. THE PREPARATION OF PYRIMIDINE AND TRIAZINE POLYMERS AND COPOLYMERS
  714. Reduction of Biguanide Complexes of Cobalt: Formation of Low Oxidation States, Stable Hydride & Organometallic Derivatives
  715. In Vitro Activity of Manuka Honey and Polyhexamethylene Biguanide on Filamentous Fungi and Toxicity to Human Cells
  716. Changes in Gene Expression in Planktonic and Biofilm Grown P. aeruginosa in Response to the Biocide Polyhexamethylene Biguanide
  717. The Antidiabetic Biguanide Metformin Induces Growth Arrest in Retinoblastoma Cells in vitro
  718. Kinetics and mechanism of oxidation of nitrogen (III) by [ethylenebis (biguanide)] silver (III) cation and its conjugate bases in aqueous perchlorate media
  719. Buformin, an anti-diabetic biguanide, inhibits proliferation, invasion and adhesion, and acts synergistically with paclitaxel in endometrial cancer cell lines
  720. STUDIES IN ANTIMALARIALS-Part X. N 1-Aryl-N 5-heterocycyclic-biguanides.
  721. Spectroscopic Studies on the Interaction of Polymeric In-chain Biguanide Biocide with Phospholipid Membranes as Probed by 8-Anilinonaphthalene-l-sulfonate
  722. Effect of N1-hexyl-N5-benzyl-biguanide mesylate (HBB) on Immediate Early Hormonal Signaling in MCF-7 Breast Cancer Cells
  723. The Effect of Reactive Dyes upon the Uptake and Antibacterial Efficacy of Poly (hexamethylene Biguanide), PHMB on Cotton, and Related Studies
  724. Complexes of Cd (II), Zn (II), Mg (II) & Al (III) Halides with Biguanides & N’-Amidinoisoureas
  725. The Anti-Bacterial Activity of Some Polyhexamethylene Biguanides Towards Escherichia coli ATCC 8739
  726. Assessment of efficacy of combined therapy with antihypertensive agents and biguanides in patients with metabolic syndrome
  727. … Site Infection Rates and Cost Benefits Associated with Plain Gauze Dressings verses Gauze Dressings Impregnated with Polyhexamethylene Biguanide  …
  728. Effect of gastrointestinal lipase inhibitor combined with biguanides on serum estrogens in polycystic ovary syndrome with infertility
  729. Blockade of the antinociception induced by diclofenac, but not of indomethacin, by sulfonylureas and biguanides
  730. Blockade of the antinociception induced by diclofenac, but not of indomethacin, by sulfonylureas and biguanides
  731. Sulphonylureas and biguanides do not affect insulin binding in H35 hepatoma cells.
  732. The Mechanism for the Reaction of Biguanides with Diethyl Oxalate
  733. Development of a fast atom bombardment tandem mass spectrometric screening method for alkyl-ended oligomeric biguanides
  734. Serum concentration of lactate in diabetic patients treated with biguanides in relationship to renal function (author’s transl)
  735. Regulation of proliferation of colon cancer cells by compounds affecting glycolysis including 3-bromopyruvate, 2-deoxyglucose and biguanides.
  736. Activity of Certain Aryl-Substituted Biguanides as Accelerators of Vulcanization
  737. Studies on Metal Biguanides
  738. Reaction of Biguanides and Related Compounds. VIII. The Condensation of Arylbiguanides and N-Amidino-O-alkylisoureas with Diketene and Ethyl Acetoacetate
  739. … -ray crystallography) and in solution (1 H and 13 C nuclear magnetic resonance spectroscopy) of 1, 3-diazetidines and pentasubstituted biguanides. X-Ray molecular …
  740. BUTYL-BIGUANIDES REDUCE SERUM HDL-CHOLESTEROL CONCENTRATION
  741. (3 chlorophenyl) biguanide
  742. Toxicology of biguanides
  743. The experience of using biguanides (metformin BMS) in patients with older non-insulin-dependent diabetes mellitus
  744. Reaction of 1, 1-(2, 2′-Oxydiethyl) biguanide with Dicyanodiamide.
  745. Metachloridine-substituted Aryl Biguanides as Possible Antimalarial Compounds
  746. The Reaction of Biguanides and Related Compounds. XI. The Interaction of Ethylene Carbonates with Aryl-biguanides and Related Compounds.
  747. … ) ETHANOL ANTIMALARIALS. PART II. QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS FOR BIGUANIDES, CARBAMIMIDATES, AND BISBIGUANIDES …
  748. Reaction of biguanides and related compounds. XII. Condensations of arylbiguanides and amidinoisoureas with isaltins.
  749. Broad-spectrum anticancer activities of the biguanides metformin and buformin in combination with 2-deoxy-glucose or WZB-117 in human lung cancer cells
  750. Synthesis and characterization of Copper(ll) and nickel(II) complexes of N1( 2-carboxyethyl)biguanide
  751. The influence of clofibrate on elevated serum lactate levels in diabetic patients treated with biguanides (author’s transl)
  752. Implications of the downregulation of stemness/reprogramming factor expression by ibuprofen and biguanides
  753. ATPS-39 Combinatory effect of a newly designed biguanide (HL156A) and temozolomide against glioblastoma tumorsphere
  754. Synthesis of Biguanides and Guanamines and Their Effect on Glycogen Phosphorylase a and Steroid Metabolism in Cultured Hepatocytes From Normal and …
  755. Biguanides inhibit proliferation and decrease estrogen receptor expression in ovarian granulosa cell tumors
  756. Diabetic hearts and biguanides-a counter-reply.
  757. Mixed Ligand Complexes of Co (III) with Biguanides & Nitric Oxide
  758. THE POSSIBILITIES TO CORRECTION CYTOKINE’S PROFILE OF STATINS AND BIGUANIDES BESIDE SICK ISCHEMIC HEAT DISEASE WITH BROKEN …
  759. Serine deprivation potentiates anti-neoplastic effects of biguanides: Inducing and targeting a novel weakness in the regulation of cancer cell metabolism
  760. Biguanides use at the early stages of insulin resistance syndrome
  761. STUDIES IN ANTIMALARIALS Part IX. N 1-Aryl-N 5-alkyl-biguanides*.
  762. The effect of mouthwashes containing biguanides on the progression of erosion in dentin
  763. Prevention by antidiabetic biguanides of the fatty liver induced by a fat diet in rabbits. Histo-pathological study.
  764. Effect of biguanides on glucose tolerance and bodyweight of overweight persons without diabetes mellitus.
  765. Reaction of Biguanides and Related Compounds. X. Formation of s-Triazinethiones by the Condensation of Arylbiguanides with 2, 3-Trithiocarbonates
  766. Reaction of biguanides and related compounds. XIII. Benzilic acid rearrangement. The reactions of 1, 2-cyclohexanedione and 9, 10-phenanthrenequinone with …
  767. Reaction of Biguanides and Related Compounds. X. Formation of s-Triazinethiones by the Condensation of Arylbiguanides with 2, 3-Trithiocarbonates
  768. CYP3A4 epoxygenase activity mediates ER+ mammary tumor growth and angiogenesis, in part, through EET biosynthesis and is inhibited by biguanides
  769. The phenanthridine biguanides efficiently differentiate between dGdC, dAdT and rArU sequences by two independent, sensitive spectroscopic methods
  770. Diabetic hearts and biguanides-a reply.
  771. Study of the Permeation of the Gram-negative Cell Envelope by Some Polyhexamethylene Biguanides
  772. The presence of mucin increases the anti-HIV-1 activity of the candidate microbicide polyethylene hexamethylene biguanide (PEHMB)
  773. Ergospirometric studies on patients with diabetes mellitus and the effect of biguanides on physical performance
  774. Reaction of Biguanides and Related Compounds. V. The Base-catalyzed Condensation of Benzil with 1, 1-Dialkylguanidine
  775. Reaction of Biguanides and Related Compounds. VI. Condensation of N-Amidino-O-alkylisourea with β-Diketone
  776. Biguanides enhance glucose utilization and insulin action in peripheral tissues: An old finding from the sixties of the last century
  777. Studies on the metabolism of ketone bodies and pyruvic acid in patients with various endocrine disorders. 3. Effects of sulfonylureas, biguanides and insulin on the …
  778. Lactic acidosis as a complication of treatment with biguanides
  779. On the Mechanism of Action of Biguanides
  780. … -{sup 14} C-2, 4 (dimethyl-1-1 biguanide) hydrochloride; Synthese du chlorhydrate de dimethyl-1, 1 guanylguanidine {sup 14} C-2, 4 (dimethyl-1-1 biguanide)
  781. Synthesis of dimethyl-1,1 guanylguanidine-14C-2,4 (dimethyl-1-1 biguanide) hydrochloride
  782. Semi-automatic determination of blood lactate during hypoglycemic treatment with biguanides
  783. Treatment of diabetes without biguanides. Observation on the course after changing treatment (author’s transl)
  784. EPR Study of Some Cu(II) Coordination Compounds with Substituted Biguanides, I
  785. THIOUREA DERIVATIVES FROM SULPHA BIGUANIDES
  786. Targeting tumor metabolism: biguanides as anti-neoplastic agents
  787. This is Biguanides can reduce appetite and thus
  788. Review of biguanide (metformin) toxicity
  789. Synthetic accesses to biguanide compounds
  790. Polyhexamethylene biguanide and its antimicrobial role in wound healing: a narrative review
  791. Simultaneous interfacial modification and crystallization control by biguanide hydrochloride for stable perovskite solar cells with PCE of 24.4%
  792. Biguanide iridium (III) complexes with potent antimicrobial activity
  793. Contact allergy to polyhexamethylene biguanide (polyaminopropyl biguanide)
  794. Chitosan biguanide induced mitochondrial inhibition to amplify the efficacy of oxygen-sensitive tumor therapies
  795. Insights into the polyhexamethylene biguanide (PHMB) mechanism of action on bacterial membrane and DNA: A molecular dynamics study
  796. Effect of polyhexamethylene biguanide in combination with undecylenamidopropyl betaine or PslG on biofilm clearance
  797. Carbon dioxide gas sensor based on polyhexamethylene biguanide polymer deposited on silicon nano-cylinders metasurface
  798. Preparation and characterization of a biodegradable starch-based antibacterial film containing nanocellulose and polyhexamethylene biguanide
  799. Biguanide-Derived Polymeric Nanoparticles Kill MRSA Biofilm and Suppress Infection In Vivo
  800. Biodiesel production using biguanide-functionalized hydroxyapatite-encapsulated-γ-Fe2O3 nanoparticles
  801. A structural basis for biguanide activity
  802. Biological and spectral studies of O-Tolyl Biguanide: Experimental and theoretical approach
  803. Quantification of biguanide and related compounds (anti-diabetic) in vegetables and fruits
  804. Development of carrier-free self-assembled nanoparticles based on fenhexamid and polyhexamethylene biguanide for sustainable plant disease management
  805. Covalently construction of poly (hexamethylene biguanide) as high-efficiency antibacterial coating for silicone rubber
  806. Poly (hexamethylene biguanide)(PHMB) as high-efficiency antibacterial coating for titanium substrates
  807. Fabrication of collagen with polyhexamethylene biguanide: A potential scaffold for infected wounds
  808. Fungal cell barriers and organelles are disrupted by Polyhexamethylene biguanide (PHMB)
  809. Dual crosslinked ion-based bacterial cellulose composite hydrogel containing polyhexamethylene biguanide
  810. Hyaluronic acid-methacrylic anhydride/polyhexamethylene biguanide hybrid hydrogel with antibacterial and proangiogenic functions for diabetic wound repair
  811. Bactericidal and Anti-biofilm Effects of Polyhexamethylene Biguanide in Models of Intracellular and Biofilm of Staphylococcus aureus Isolated from Bovine …
  812. Distinguishing characteristics of exposure to biguanide and sulfonylurea anti-diabetic medications in the United States
  813. Long term antibacterial effect cellulose film was modified with polyhexamethylene biguanide (PHMB)
  814. In vitro inflammatory effects of polyhexamethylene biguanide through NF-κB activation in A549 cells
  815. Safety and tolerability of topical polyhexamethylene biguanide: a randomised clinical trial in healthy adult volunteers
  816. Autolytic debridement and management of bacterial load with an occlusive hydroactive deressing impregnated with polyhexamethylene biguanide
  817. Antimicrobial effectiveness of polyhexamethylene biguanide on Enterococcus faecalis, Staphylococcus epidermidis and Candida albicans.
  818. First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors
  819. Influence of the incorporation of the antimicrobial agent polyhexamethylene biguanide on the properties of dense and porous chitosan-alginate membranes
  820. Antibacterial efficacy of chitosan-and poly (hexamethylene biguanide)-immobilized nanofiber membrane
  821. Characterizing clinical isolates of Acanthamoeba castellanii with high resistance to polyhexamethylene biguanide in Taiwan
  822. Molluscicidal activity of polyhexamethylene biguanide hydrochloride on the early-life stages and adults of the Biomphalaria glabrata (Say, 1818)
  823. Polyhexamethylene biguanide chemically modified cotton with desirable hemostatic, inflammation-reducing, intrinsic antibacterial property for infected wound healing
  824. Inflammatory reaction, clinical efficacy, and safety of bacterial cellulose wound dressing containing silk sericin and polyhexamethylene biguanide for wound treatment
  825. Novel biguanide-based derivatives scouted as TAAR1 agonists: Synthesis, biological evaluation, ADME prediction and molecular docking studies
  826. Modulatory contribution of oxygenating hydrogels and polyhexamethylene biguanide on the antimicrobial potency of neutrophil-like cells
  827. Preparation of long-lasting antibacterial wound dressing through diffusion of cationic-liposome-encapsulated polyhexamethylene biguanide
  828. A facile preparation process of polyhexamethylene biguanide/cellulose/polylactic acid fiber composite antibacterial paper
  829. Multifunctional antimicrobial and flame retardant cotton fabrics modified with a novel N, N-di (ethyl phosphate) biguanide
  830. Effect of polyhexamethylene biguanide solution on bacterial load and biofilm in venous leg ulcers: a randomized controlled trial
  831. In Vitro activity of Manuka Honey and polyhexamethylene biguanide on filamentous fungi and toxicity to human cell lines
  832. Toxic potential of Poly-hexamethylene biguanide hydrochloride (PHMB): A DFT, AIM and NCI analysis study with solvent effects
  833. Antimicrobial effectiveness of wound matrices containing native extracellular matrix with polyhexamethylene biguanide
  834. Synthesis, Structural Investigations, and In Vitro/In Silico Bioactivities of Flavonoid Substituted Biguanide: A Novel Schiff Base and Its Diorganotin (IV) …
  835. Polyhexamethylene biguanide: polyurethane blend nanofibrous membranes for wound infection control
  836. Preparation of nano cationic liposome as carrier membrane for polyhexamethylene biguanide chloride through various methods utilizing higher antibacterial activities …
  837. Repurposed biguanide drugs in glioblastoma exert antiproliferative effects via the inhibition of intracellular chloride channel 1 activity
  838. IgE‐mediated chlorhexidine allergy—Cross‐reactivity with other biguanide disinfectants
  839. A novel cationic waterborne polyurethane coating modified by chitosan biguanide hydrochloride with application potential in medical catheters
  840. Effect of a new purified collagen matrix with polyhexamethylene biguanide on recalcitrant wounds of various etiologies: a case series.
  841. New optoelectronic material based on biguanide for orange and yellow organic light emitting diode: A combined experimental and theoretical study
  842. DFT studies of nanomaterials designed by the functionalization of modified carboxylated carbon nanotubes with biguanide derivatives for nanomedical, nonlinear and …
  843. Synthesis and characterization of biguanide and biguanidium surfactants for efficient and recyclable application in the Suzuki–Miyaura reaction
  844. Safety of intrastromal injection of polyhexamethylene biguanide and propamidine isethionate in a rabbit model
  845. Biguanide-functionalized hierarchical porous covalent organic frameworks for efficient catalysis of condensation reactions
  846. Cytotoxicity and molecular effects of biocidal disinfectants (quaternary ammonia, glutaraldehyde, poly (hexamethylene biguanide) hydrochloride PHMB) and their …
  847. Biguanide drugs enhance cytotoxic effects of cisplatin by depleting aspartate and NAD+ in sensitive cancer cells
  848. Polyhexamethylene biguanide hydrochloride anchored polymeric elastic fibers with robust antibacterial performance
  849. Anti-biofilm activity of povidone-iodine and Polyhexamethylene biguanide: evidence from In vitro tests
  850. Study on the development of antiviral spandex fabric coated with poly (hexamethylene biguanide) hydrochloride (PHMB)
  851. A new perspective on the biguanide, metformin therapy in type 2 diabetes and lactic acidosis
  852. Durable superhydrophobic and antimicrobial cotton fabrics prepared by electrostatic assembly of polyhexamethylene biguanide and subsequent hydrophobization
  853. Biguanide–transition metals complexes as potential drug for hyperglycemia treatment
  854. Mapping of biguanide transporters in human fat cells and their impact on lipolysis
  855. Biguanide Mc001, a dual inhibitor of oxphos and glycolysis, shows enhanced antitumor activity without increasing lactate production
  856. Use of native type I collagen matrix plus polyhexamethylene biguanide for chronic wound treatment
  857. Poly (hexamethylene biguanide): an efficient pH-tolerant and salt-intensive flocculant in the removal of anionic dyes from wastewater
  858. Longitudinal Study on the Antimicrobial Performance of a Polyhexamethylene Biguanide (PHMB)-Treated Textile Fabric in a Hospital Environment
  859. Safety assessment of polyaminopropyl biguanide (polyhexamethylene biguanide hydrochloride) as used in cosmetics
  860. Mechanical, antibacterial, biocompatible and microleakage evaluation of glass ionomer cement modified by nanohydroxyapatite/polyhexamethylene biguanide
  861. Development of bacterial cellulose incorporating silk sericin, polyhexamethylene biguanide, and glycerin with enhanced physical properties and antibacterial activities …
  862. Charge density analysis of metformin chloride, a biguanide anti-hyperglycemic agent
  863. The biguanide polyamine analog verlindamycin promotes differentiation in neuroblastoma via induction of antizyme
  864. A novel biocompatible antibacterial product: Nanoliposomes loaded with poly (hexamethylene biguanide chloride)
  865. Effectiveness of polyhexamethylene biguanide, chlorhexidine, and calcium hydroxide intracanal medicament against intraradicular mature polymicrobial …
  866. Effect of native type I collagen with polyhexamethylene biguanide antimicrobial on wounds: interim registry results
  867. Guanidine-based disinfectants, polyhexamethylene guanidine-phosphate (PHMG-P), polyhexamethylene biguanide (PHMB), and oligo (2-(2-ethoxy) ethoxyethyl …
  868. Biguanide, an Efficient Electrofreezing “Ice-maker” Ion of Supercooled Water
  869. Novel potent antiplatelet thrombotic agent derived from biguanide for ischemic stroke
  870. Porous poly (hexamethylene biguanide) hydrochloride loaded silk fibroin sponges with antibacterial function
  871. Chlorhexidine gluconate or polyhexamethylene biguanide disc dressing to reduce the incidence of central-line-associated bloodstream infection: a feasibility …
  872. Biosafety evaluation and quantitative determination of poly (hexamethylene biguanide)(PHMB) coated on cellulosic fabrics by Kubelka–Munk equation
  873. Phase I study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors.
  874. Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide …
  875. Type I collagen matrix plus polyhexamethylene biguanide antimicrobial for the treatment of cutaneous wounds
  876. Polyhexamethylene biguanide hydrochloride (PHMB)-properties and application of an antiseptic agent. A narrative review
  877. Insight on Ni (II) and Cu (II) complexes of biguanide derivatives developed as effective antimicrobial and antitumour agents
  878. Cellular gene delivery via poly (hexamethylene biguanide)/pDNA self-assembled nanoparticles
  879. The biguanide–sulfonamide derivatives: synthesis, characterization and investigation of anticholinesterase inhibitory, antioxidant and DNA/BSA binding properties
  880. Metformin-based carbon dots based on biguanide functional groups for simultaneous chelation of copper ions and inhibitable colorectal cancer therapy
  881. … of topical 1% voriconazole ophthalmic solution as monotherapy with combination therapy of topical 0.02% polyhexamethylene biguanide and 0.02% chlorhexidine in …
  882. A case of severe anaphylaxis to polyhexanide: cross-reactivity between biguanide antiseptics
  883. A biodegradable poly (amido amine) based on the antimicrobial polymer polyhexamethylene biguanide for efficient and safe gene delivery
  884. Layer-by-layer construction of zwitterionic/biguanide polymers on silicone rubber as an antifouling and bactericidal coating
  885. Biguanide pharmaceutical formulations and the applications of bile acid-based nano delivery in chronic medical conditions
  886. Stability of an ophthalmic formulation of polyhexamethylene biguanide in gamma-sterilized and ethylene oxide sterilized low density polyethylene multidose …
  887. A novel zinc oxide eugenol modified by polyhexamethylene biguanide: Physical and antimicrobial properties
  888. Comparison of decision tree with common machine learning models for prediction of biguanide and sulfonylurea poisoning in the United States: an analysis of …
  889. Synthesis, crystal structure, the Hirshfeld surface analysis, and antimicrobial activity of a three-dimensional Cu (II) complex with N-substituted biguanide
  890. Magnolol-loaded cholesteryl biguanide conjugate hydrochloride nanoparticles for triple-negative breast cancer therapy
  891. Antibacterial efficacy of poly (hexamethylene biguanide) immobilized on chitosan/dye-modified nanofiber membranes
  892. Biguanide-based synthesis of 1, 3, 5-triazine derivatives with anticancer activity and 1, 3, 5-triazine incorporated calcium citrate nanoparticles
  893. Structural basis of mammalian respiratory complex I inhibition by medicinal biguanides
  894. Anticancer properties of novel pyrazole‐containing biguanide derivatives with activating the adenosine monophosphate‐activated protein kinase signaling pathway
  895. Determination of polyhexamethylene biguanide utilizing a glucose oxidase enzymatic reaction
  896. Evaluation of in vitro bactericidal activity of 1.5% olanexidine gluconate, a novel biguanide antiseptic agent
  897. Polyhexamethylene biguanide and nadifloxacin self-assembled nanoparticles: Antimicrobial effects against intracellular methicillin-resistant Staphylococcus aureus
  898. Polyvinyl alcohol/chitosan/polyhexamethylene biguanide phase separation system: A potential topical antibacterial formulation with enhanced antimicrobial effect
  899. Geographic variation in and contextual factors related to biguanide adherence amongst medicaid enrolees with type 2 Diabetes Mellitus
  900. Biguanide is a modifiable pharmacophore for recruitment of endogenous Zn2+ to inhibit cysteinyl cathepsins: review and implications
  901. A novel biguanide (IM1761065) inhibits bioenergetics of glioblastoma tumorspheres
  902. Repurposing the Bis-Biguanide Alexidine in Combination with Tyrosine Kinase Inhibitors to Eliminate Leukemic Stem/Progenitor Cells in Chronic Myeloid Leukemia
  903. Plasmonic Perfect Absorber Utilizing Polyhexamethylene Biguanide Polymer for Carbon Dioxide Gas Sensing Application
  904. … due to Tintelnotia destructans refractory to common therapy treated successfully with systemic and local terbinafine in combination with polyhexamethylene biguanide
  905. Therapeutic repurposing of biguanides in cancer
  906. Biguanides: Species with versatile therapeutic applications
  907. The synthesis of thermostable, strongly basic Anion-Exchange resins using Cross-Linked biguanide and its application in the extraction of Sodium copper …
  908. Inhibition of chloride intracellular channel 1 (CLIC1) as biguanide class-effect to impair human glioblastoma stem cell viability
  909. Cellulose Powder Functionalized with Phenyl Biguanide: Synthesis, Cross-Linking, Metal Adsorption, and Molecular Docking
  910. Inhaled biguanides and mTOR inhibition for influenza and coronavirus
  911. Incorporation of a biguanide scaffold enhances drug uptake by organic cation transporters 1 and 2
  912. Mono-and Dinuclear Aluminium Complexes Derived from Biguanide and Carbothiamide Ligands
  913. Cytochrome P450 monooxygenase of Acanthamoeba castellanii participates in resistance to polyhexamethylene biguanide treatment
  914. “What’s in a structure?” The story of biguanides
  915. Translational and HIF-1α-dependent metabolic reprogramming underpin metabolic plasticity and responses to kinase inhibitors and biguanides
  916. Polyhexamethylene biguanide and chloroquine induce programmed cell death in Acanthamoeba castellanii
  917. The mechanism of action of biguanides: New answers to a complex question
  918. Association of hydroxylmethyl glutaryl coenzyme A reductase inhibitors, L-type calcium channel antagonists, and biguanides with rates of psychiatric hospitalization …
  919. A biguanide derivative and its cyclic anologue: Structural chracterization, AChE inhibitory effect and docking studies
  920. Prediction of electronic and vibrational properties of poly (hexamethylene biguanide) hydrochloride: A combined theoretical and experimental investigation
  921. Biguanide-dihydropyrimidine dual scaffolds with impressive basicities according to DFT calculations
  922. A comparison of the effects of topical prolavacid solution (a polyhexamethylene biguanide-based wound cleanser) and medihoney ointment in a rat model of …
  923. Biguanides drugs: past success stories and promising future for drug discovery
  924. Effect of polyhexamethylene biguanide on rat liver
  925. Type 2 diabetes in neuroendocrine tumors: are biguanides and statins part of the solution?
  926. Synthesis and in vitro activity of new biguanide-containing dendrimers on pathogenic isolates of Acanthamoeba polyphaga and Acanthamoeba griffini
  927. Ex vivo wound model on porcine skin for the evaluation of the antibiofilm activity of polyhexamethylene biguanide and ciprofloxacin
  928. B-and Al-Doped Porous 2D Covalent Organic Frameworks as Nanocarriers for Biguanides and Metformin Drugs
  929. A study of long-term stability and antimicrobial activity of chlorhexidine, polyhexamethylene biguanide, and silver nanoparticle incorporated in sericin-based wound …
  930. Biguanides exert antitumoral actions in pituitary tumor cells through AMPK-dependent and-independent mechanisms
  931. Clinical, cellular, and molecular evidence of the additive antitumor effects of biguanides and statins in prostate cancer
  932. Poly (hexamethylene biguanide) salicylate as a novel ionic liquid with antibacterial properties in the production of poly (vinyl alcohol) films
  933. Incorporation of biguanide compounds into poly (GL)-b-poly (GL-co-TMC-co-CL)-b-poly (GL) monofilament surgical sutures
  934. Metabolic rewiring in response to biguanides is mediated by mROS/HIF-1a in malignant lymphocytes
  935. Modelling of Tungsten (C59W), Osmium (C59Os), and Platinum (C59Pt) Doped Fullerenes for Drug Delivery of Biguanides (BNG) and Metformin (MET): DFT …
  936. Repression of LKB1 by miR-17∼ 92 sensitizes MYC-dependent lymphoma to biguanide treatment
  937. Antimicrobial activity of polyhexamethylene biguanide nanoparticles against mastitis-causing Staphylococcus aureus
  938. Heme binding biguanides target cytochrome P450-dependent cancer cell mitochondria
  939. The dramatic recovery of a patient with biguanide-associated severe lactic acidosis following thiamine supplementation
  940. Effectiveness of a polyhexamethylene biguanide-containing wound cleansing solution using experimental biofilm models
  941. Effect of Local Administration of Meglumine Antimoniate and Polyhexamethylene Biguanide Alone or in Combination with a Toll-like Receptor 4 Agonist for …
  942. Preparation of an antibacterial dressing for simultaneous delivery of polyhexamethylene biguanide and platelet-rich plasma, and evaluation of the dressing’s ability to …
  943. Salting-out assisted liquid-liquid extraction coupled with hydrophilic interaction chromatography for the determination of biguanides in biological and environmental …
  944. Polyhexamethylene Biguanide Multipurpose Solutions on Bacterial Disinfection: A Comparison Study of Effectiveness in a Developing Country
  945. Copper-catalyzed synthesis of substituted 2, 4-diamino-1, 3, 5-triazines from 1, 1-dibromoalkenes and biguanides
  946. Effect of poly-hexamethylene biguanide hydrochloride (PHMB) treated non-sterile medical gloves upon the transmission of Streptococcus pyogenes …
  947. Low-frequency ultrasonic debridement and topical antimicrobial polyhexamethylene biguanide for use in chronic wounds: A case series
  948. Rational design, chemical synthesis and biological evaluation of novel biguanides exploring species-specificity responsiveness of TAAR1 agonists
  949. Graphene oxide as a carbo-catalyst for the synthesis of tri-substituted 1, 3, 5-triazines using biguanides and alcohols
  950. Antidiabetic biguanides radiosensitize hypoxic colorectal cancer cells through a decrease in oxygen consumption
  951. A novel biguanide derivative, IM176, induces prostate cancer cell death by modulating the AMPK-mTOR and androgen receptor signaling pathways
  952. Preparation and properties of antibacterial polyhexamethylene biguanide/palygorskite composites as zearalenone adsorbents
  953. Results from 11C-metformin-PET scans, tissue analysis and cellular drug-sensitivity assays questions the view that biguanides affects tumor respiration …
  954. Biguanide antidiabetic drugs: imeglimin exhibits higher proton basicity but smaller lithium-cation basicity than metformin in vacuo
  955. Pleiotropic effects of biguanides on mitochondrial reactive oxygen species production
  956. A study of the effects of metformin, a biguanide derivative, on annulus fibrosus and nucleus pulposus cells
  957. The biguanides metformin and buformin in combination with 2-deoxy-glucose or WZB-117 inhibit the viability of highly resistant human lung cancer cells
  958. Effect of polyhexamethylene biguanide functionalized silver nanoparticles on the growth of Staphylococcus aureus
  959. The Effects of Polyhexamethylene Biguanide (PHMB) and TLR Agonists Alone or as Polyplex Nanoparticles against Leishmania infantum Promastigotes and …
  960. Mechanism of Polyhexamethylene Biguanide Resistance in Purpureocillium lilacinum Strains
  961. Ruthenium-catalyzed synthesis of arylethyl 1, 3, 5-triazines from arylallyl alcohols and biguanides
  962. Effects of biguanides on growth and glycolysis of bladder and colon cancer cells
  963. Poly (hexamethylene biguanide), adsorbed onto Ti‐Al‐V alloys, kills slime‐producing Staphylococci and Pseudomonas aeruginosa without inhibiting SaOs‐2 cell …
  964. Effects of first-line diabetes therapy with biguanides, sulphonylurea and thiazolidinediones on the differentiation, proliferation and apoptosis of islet cell …
  965. Selection of a Gentamicin-Resistant Variant Following Polyhexamethylene Biguanide (PHMB) Exposure in Escherichia coli Biofilms
  966. Uptake and release of polyhexamethylene biguanide (PHMB) from hydrogel and silicone hydrogel contact lenses using a radiolabel methodology
  967. Micropore Particle Technology Promotes Wound Healing, Whereas Polyhexamethylene Biguanide Causes Tissue Degeneration: A Case Report.
  968. Safety assessment of Polyhexamethylene biguanide
  969. Sulfonylureas or biguanides is associated with a lower risk of rheumatoid arthritis in patients with diabetes: A nationwide cohort study
  970. Rapid detection of illegal biguanides in hypoglycemic health products using molecular imprinting combined with SERS technology
  971. Allergic contact dermatitis caused by poly (hexamethylene) biguanide hydrochloride in contact lens care solutions
  972. Synthesis of antibacterial polyether biguanide curing agent and its cured antibacterial epoxy resin
  973. Entering the sugar rush era: revisiting the antihyperglycemic activities of biguanides after a century of metformin discovery
  974. New biguanides as anti-diabetic agents part I: synthesis and evaluation of 1-substituted biguanide derivatives as anti-diabetic agents of type II diabetes insulin …
  975. Development of antitumor biguanides targeting energy metabolism and stress responses in the tumor microenvironment
  976. Synthesis and Coordination Chemistry of 3, 4-Ethylene-Bridged 1, 1, 2, 5-Tetrasubstituted Biguanides
  977. Investigation of the clinical effectiveness of polyhexanid/polyhexamethylene biguanide wound dressing in chronic cases
  978. Biguanides in combination with olaparib limits tumorigenesis of drug‐resistant ovarian cancer cells through inhibition of Snail
  979. Biguanides decorated albumin nanoparticles loading nintedanib for synergic enhanced hepatocellular carcinoma therapy
  980. Copper(II) species with 1‐(o‐tolyl)biguanide: Structural characterization, ROS scavenging, antibacterial activity, biocompatibility and in silico studies
  981. High fill factor over 82% enabled by a biguanide doping electron transporting layer in planar perovskite solar cells
  982. Cobalt complexes with biguanide derivatives–Synthesis, structure and antiviral activity
  983. Biguanides Metformin and Phenformin Generate Therapeutic Effects via AMP-Activated Protein Kinase/Extracellular-Regulated Kinase Pathways in an In Vitro Model …
  984. Polyhexamethylene biguanide discs versus unmedicated dressings for prevention of central venous catheter–associated infection in the intensive care unit: A …
  985. Cardiac Dysfunction Due to Thiamine Deficiency after Hemodialysis for Biguanide-related Lactic Acidosis
  986. Incorporation of sulfonamide moiety into biguanide scaffold results in apoptosis induction and cell cycle arrest in MCF-7 breast cancer cells
  987. Comparative evaluation of substantivity of two biguanides-0.2% polyhexanide and 2% chlorhexidine on human dentin
  988. Chitooligosaccharide Biguanide Repairs Islet β‐Cell Dysfunction by Activating the IRS‐2/PI3K/Akt Signaling Pathway in Type 2 Diabetic Rats
  989. Microbiological identification and resistance profile of microorganisms in pressure injuries after the use of polyhexamethylene biguanide: a series of fourteen cases.
  990. Synthesis, Anticancer Activities, and Mechanism of N-heptyl-containing Biguanide Derivatives
  991. Regulatory Effects of Metformin, an Antidiabetic Biguanide Drug, on the Metabolism of Primary Rat Adipocytes
  992. Coating of 2-Aminobenzimidiazole and 1-(o-Tolyl) biguanide Functionalized Silicas on Iron Sand Magnetic Material for Sorption of [AuCl4]
  993. Biguanides enhance antifungal activity against Candida glabrata
  994. The chemistry of biguanides: from synthetic routes to applications in organic chemistry
  995. Enhanced killing of Escherichia coli using a combination of polyhexamethylene biguanide hydrochloride and 1-bromo-3-chloro-5,5- dimethylimidazolidine-2,4-dione
  996. Use of low-frequency contact ultrasonic debridement with and without polyhexamethylene biguanide in hard-to-heal leg ulcers: an RCT
  997. Phenylethynylbenzyl-modified biguanides inhibit pancreatic cancer tumor growth
  998. Determination of polyhexamethylene biguanide hydrochloride using a lactone-rhodamine b-based fluorescence optode
  999. Sodium hexametaphosphate-treated halloysite based solid-phase extraction of biguanides from dietary supplements
  1000. Gas phase basicity of biguanides–Comparison of the equilibrium and the kinetic methods
  1001. Biguanides, anion receptors and sensors
  1002. Glucose deprivation enhances the antiproliferative effects of oral hypoglycemic biguanides in different molecular subtypes of breast cancer: An in vitro study
  1003. Novel halogenated sulfonamide biguanides with anti-coagulation properties
  1004. Risk of Lactic Acidosis in Hospitalized Diabetic Patients Prescribed Biguanides in Japan: A Retrospective Total-Population Cohort Study
  1005. Biguanide-and Oligo (Ethylene Glycol)-Functionalized Poly (3, 4-Ethylenedioxythiophene): Electroactive, Antimicrobial, and Antifouling Surface Coatings
  1006. Fabrication of novel antimicrobial bio-fibers using silk wastage, study of poly (hexamethylene) biguanide, and silver nanoparticles interaction
  1007. Water soluble biguanide salts and their 1, 3, 5-triazine derivatives as inhibitors of acetylcholinesterase and α-glucosidase
  1008. Improved Adsorption of the Antimicrobial Agent Poly (Hexamethylene) Biguanide on Ti-Al-V Alloys by NaOH Treatment and Impact of Mass Coverage and …
  1009. Pharmaceutical properties of a tinted formulation of a biguanide antiseptic agent, olanexidine gluconate
  1010. Analysis of povidone iodine, chlorhexidine acetate and polyhexamethylene biguanide as wound disinfectants: in vitro cytotoxicity and antibacterial activity
  1011. Histone deacetylase inhibitors enhance the amoebicidal effect of low concentration of polyhexamethylene biguanide by inducing apoptosis
  1012. Isolation and characterization of the polyhexamethylene biguanide hydrochloride-resistant fungus, Purpureocillium lilacinum
  1013. Fungicidal, corrosive, and mutational effects of polyhexamethylene biguanide combined with 1-bromo-3-chloro-5, 5-dimethylimidazolidine-2, 4-dione
  1014. Three Consecutive Cases of Ocular Polyhexamethylene Biguanide (PHMB) Toxicity Due to Compounding Error
  1015. Synthesis, physico‐chemical characterization and bioevaluation of Ni(II), Pd(II), and Pt(II) complexes with 1‐(o‐tolyl)biguanide: Antimicrobial and antitumor studies
  1016. Structural features influencing the activity of bis-biguanide ligands in the Suzuki–Miyaura cross-coupling reaction in neat water
  1017. … of Rose Bengal photoactivated by green light associated or not to Propamidine Isethionate and/or Polyhexamethyl Biguanide on Acanthamoeba trophozoites …
  1018. Use of low-frequency contact ultrasonic debridement with and without polyhexamethylene biguanide in hard-to-heal leg ulcers: an RCT protocol
  1019. Comparative toxicological analysis of metformin (Biguanide) and glibenclamide (Sulfonylureas), using zebrafish embryotoxicity test (ZFET)
  1020. Flow injection spectrophotometric determination of polyhexamethylene biguanide hydrochloride in contact-lens detergents using anionic dyes
  1021. Energy metabolism modulation by biguanides in comparison with rotenone in rat liver and heart
  1022. Comparison of the effects of povidone-iodine 5%, polyhexamethylene biguanide, and chlorhexidine as a preoperative antiseptic in endophthalmitis …
  1023. NBR2-GLUT1 axis regulates cancer cell sensitivity to biguanides
  1024. Mechanistic considerations of Catharanthus roseus on the hypo-glycemic activity of alpha glucosidase inhibitors and biguanides: A review
  1025. In vitro efficacy of a 0.2% polyhexamethylene biguanide‐impregnated gauze dressing against pathogenic bacterial isolates found in horses
  1026. Glucophage®(metformin hydrochloride), the wonder drug: a biguanide class treatment of type 2 diabetes
  1027. Synthesis of gamma biguanides butyric acid analogues as HDAC inhibitors and studying their cytotoxic activity
  1028. Comparison of effectiveness and drug cost between dipeptidyl peptidase‐4 inhibitor and biguanide as the first‐line anti‐hyperglycaemic medication among Japanese …
  1029. A New High Performance Biguanide Polyammonium-Based Blend for Control of Microbiological Fouling in Oil and Gas Stimulation
  1030. Synthesis of sugar-biguanide hybrids to study their potential biological effects
  1031. Synthesis of a Stable, Water‐Tolerant, Short Mesoporous Organic Biguanide, Strong Solid Base and Its Application in Catalysis
  1032. Novel function of biguanides in inhibition of phospholipase D1 expression via a translational mechanism in cancer cells
  1033. Effect of combined therapy polyhexamethylene biguanide and Coriolus-MRL on human papilloma virus (HPV) cervical and vulvar-related lesions
  1034. A review on analytical methods for determination of oral anti-diabetic drugs like biguanides, gliptins and gliflozins in bulk and in pharmaceutical dosage forms
  1035. Polyhexamethylene biguanide for chronic wounds
  1036. Genotyping panel to assess Hand-Foot Syndrome in T2DM and cancer patients who receive concurrent Platin derivates and Biguanides
  1037. Application possibilities of biguanides for fibrocystic breast disease in women of reproductive age
  1038. 1-n-heptyl-5-(3, 4-difluorophenyl) biguanide inhibits non-small cell lung cancer cell growth by downregulating the EGFR signaling pathways
  1039. Studying the Cytotoxic Activity of Newly Designed and Synthesized HDAC Inhibitors Derivatives of Pentanoyl Anilide‐5‐Biguanide
  1040. Effectiveness of type I collagen matrix plus polyhexamethylene biguanide antimicrobial for the treatment of pressure injuries
  1041. The Combination of Polyhexamethylene Biguanide and Cadexomer Iodine in Healing Chronic Venous Leg Ulcers: A Case Report
  1042. The effect of biguanide derivatives on antioxidant status during the development of oxidative stress
  1043. The effect of biguanide derivatives on oxidative stress in rats with hyperglycemia
  1044. Tackling Triple-Negative Breast Cancer with a Novel Glucose Transporter Inhibitor and an Antidiabetic Biguanide
  1045. ARB AND BIGUANIDE TAILORED BILAYER TABLET: AS POTENTIAL APPROACH IN EFFECTIVE THERAPEUTIC MANAGEMENT OF DIABETIC PATIENTS HAVING …
  1046. A single-center pilot study investigating the effects of a native cross-linked extracellular matrix with polyhexamethylene biguanide to manage chronic lower extremity …
  1047. Biguanides Induce Acute de novo Lipogenesis in Human Primary Sebocytes
  1048. Effect of fish collagen and poly (hexamethylene biguanide) hydrochloride on the content of micro-and macroelements in maize plants
  1049. Harnessing the gene delivery, anti-cancer and antimicrobial potential of polyethylene biguanides and their nanotized forms
  1050. Polyhexamethylene biguanide combined with poloxamer 188 in the local treatment of chronic wounds of vascular aetiology–own experience and practice
  1051. Design and in vitro characterization of novel pulsatile delivery system of biguanide antidiabetic drug
  1052. Polyhexamethylene biguanide versus saline on microbial load in wounds: a systematic review protocol.
  1053. Balance of disinfection and cytotoxicity of hydroxypropyltrimethyl ammonium chloride chitosan with polyhexamethylene biguanide at low concentrations
  1054. New Biguanides as Anti‐Diabetic Agents, Part II: Synthesis and Anti‐Diabetic Properties Evaluation of 1‐Arylamidebiguanide Derivatives as Agents of Insulin …
  1055. … of topical 1% voriconazole ophthalmic solution as monotherapy with combination therapy of topical 0.02% polyhexamethylene biguanide and 0.02% chlorhexidine in …
  1056. Antineoplastic Activity of an Old Natural Antidiabetic Biguanide on the Human Thyroid Carcinoma Cell Line
  1057. Polyhexamethylene biguanide dressings on the treatment of a wound. Case report
  1058. Analysis of polyhexamethylene biguanide and alexidine in contact lens solutions using capillary electrophoresis, ultra-performance liquid chromatography and …
  1059. A Prospective Noninterventional Study of Type I Collagen Matrix Plus Polyhexamethylene Biguanide Antimicrobial for the Treatment of Venous Leg Ulcers: A …
  1060. Metabolic Cancer Therapy Using Graphene Drug Carriers: A study of biguanide drug effects in cellular and zebrafish larvae model systems
  1061. A Study of Biguanides in the Care of Type II DIABETES Mellitus
  1062. Synthesis, characterization, and biological activity of some complex combinations of nickel with α-ketoglutaric acid and 1-(o-tolyl) biguanide
  1063. Safety and tolerability of topical polyhexamethylene biguanide (PHMB): a randomised clinical trial in healthy adult volunteers
  1064. Polyhexamethylene Biguanide-Betaine Dressing Combined with Silver Sulfadiazine for Biofilm Control in an Advanced Cancer Wound: A Case Report
  1065. WHAM evidence summary: Polyhexamethylene biguanide for chronic wounds
  1066. Formation, properties and stability of poly (hexamethylene biguanide) stabilised silver nanoparticles from the perspective of novel antimicrobial agents
  1067. Carbon dioxide gas sensor based on polyhexamethylene biguanide polymer deposited on silicon Nano-cylinders metasurface
  1068. Evaluation of Rationality in Prescribing Metformin (Biguanide Group) at Dr. Mohammad Hoesin General Hospital Palembang
  1069. Complexes of Cu (II) with α-Ketoglutaric Acid and Biguanide
  1070. … of topical 1% Voriconazole ophthalmic solution as monotherapy to combination therapy with topical 0.02% Polyhexamethylene biguanide and 0.02% Chlorhexidine …
  1071. New ionic liquids based on the biguanide cation with antimicrobial properties for applications in the textile and polymer materials industries
  1072. Determination of polyaminopropyl biguanide in cosmetics by high performance liquid chromatography
  1073. Polyhexamethylene biguanide discs versus unmedicated dressings for prevention of central venous cathetereassociated infection in the intensive care unit: A …
  1074. Three Cases of Lactic Acidosis Caused by Biguanides
  1075. From Synthalin to Metformin: is a Century Cycle of Biguanides as Oral Antidiabetic drugs Now Closed?
  1076. Antidiabetic biguanides as anti-aging drugs
  1077. The synthesis and characterization of Bis-(biguanide-p-phenyl) methane
  1078. Mild Biamidine-Transfer Conditions for the Synthesis of Aliphatic Biguanides
  1079. FEATURES OF BIGUANIDES IN COMBINATION THERAPY OF HYPERTENSION WITH METABOLIC SYNDROME
  1080. Context for Practice: Polyhexamethylene Biguanide and Wound Care: Cutting-Edge Evidence
  1081. Design and In Vivo Characterization of Novel Pulsatile Drug Delivery System of Biguanide Anti-Diabetic.
  1082. The Acceptability and Efficacy of Polyhexamethylene Biguanide Post-Low-Frequency Ultrasonic Debridement in Reducing Bacterial Burden for Patients with Chronic …
  1083. Crystal Structure of Cu (II)-Bis-Morpholine Biguanide
  1084. EFEKTIVITITAS TEKNIK DAN DURASI POLYHEXAMETHYLENE BIGUANIDE (PHMB) 0, 3% SEBAGAI CAIRAN PENCUCI LUKA TERHADAP KONTROL INFEKSI …
  1085. A novel biguanide as a potential head and neck cancer therapeutic in Fanconi anemia
  1086. Polyhexamethylene Biguanide Release by Chitosan-Heparin Nanoparticles
  1087. Polyhexamethylene Biguanide Functionalized Hyperbranched Polymers Enhance Their Antimicrobial Activities
  1088. Development of an Antimicrobial and Antifouling Pes Membrane with Zno/Poly (Hexamethylene Biguanide) Nanocomposites Incorporation
  1089. Data for Biguanide iridium (III) complexes with potent antimicrobial activity
  1090. Comparing adaptive prostate cancer cell metabolism following anti-androgen and biguanide treatment
  1091. NT1195, a novel biguanide, exhibits superior uterine penetration and anti-tumorigenic efficacy as compared to metformin/phenformin in endometrial cancer
  1092. Poly (hexamethylene biguanide), adsorbed onto Ti-Al-V alloys
  1093. Author Correction: Bis-biguanide dihydrochloride inhibits intracellular replication of M. tuberculosis and controls infection in mice
  1094. Effect of 4-Methyl-Phenyl Biguanide on Free Radical Homeostasis and Activity of Oxidative Metabolism Enzymes in Rats with Cardiovascular Pathology Developing …
  1095. An X-Ray Study of Nickel Biguanide Chloride [Ni (C2N5H7) 2] Cl2, 2H2O
  1096. Opinion of the scientific committee on consumer safety (SCCS)-Final opinion on Polyaminopropyl Biguanide (PHMB) in cosmetic products-Submission III
  1097. Comparative embryotoxicological analysis of metformin (Biguanide) and glibenclamide (Sulfonylureas), using Zebrafish Embryotoxicity Test (ZFET)
  1098. PMU6 EFFECTIVENESS OF A NATIVE TYPE I COLLAGEN MATRIX PLUS POLYHEXAMETHYLENE BIGUANIDE ANTIMICROBIAL (PHMB) FOR THE TREATMENT …
  1099. Adherence to Oral Antihyperglycemic Agents (Dipeptidyl Peptidase-4 Inhibitors and Biguanides) and Its Associated Factors in Patients with Type 2 Diabetes
  1100. Three Cases of Lactic Acidosis Caused by Biguanides
  1101. On the Action of N1, N1-Anhydro-bis (β-hydroxyethyl)-Biguanide Hydrochloride (Abitylguanide, Moroxidine, ABOB) Versus RNA Viruses
  1102. Synthesis of a biotin-functionalized biguanide for the identification of the tumor growth inhibition mechanism of metformin
  1103. EXPLORING THE POTENTIAL FOR QUERCETIN-POTENTIATION OF THE CARDIOVASCULAR EFFECTS OF METFORMIN, A BIGUANIDE ANTIDIABETIC DRUG
  1104. ROLE OF POLY HEXA METHYLENE BIGUANIDE (PHMB) IN WOUND BED PREPARATION: REPORT OF A SUCCESSFULLY MANAGED CASE
  1105. N1-hexyl-N5-benzyl-biguanide promotes proliferation of CD4+ and CD8+ T lymphocytes
  1106. … EFFECTIVENESS RESEARCH STUDY OF A NATIVE TYPE I COLLAGEN MATRIX PLUS POLYHEXAMETHYLENE BIGUANIDE ANTIMICROBIAL AND A …
  1107. Management of complex abscess wounds post saucerisation using negative pressure wound therapy with polyhexamethylene biguanide instillation: Case series
  1108. Combined androgen deprivation and biguanide treatment modulates autophagy and apoptosis in prostate cancer cells
  1109. Abstract P3-06-16: Synergistic effect of biguanides and fatty acid β-oxidation inhibitor in triple-negative breast cancers
  1110. Treatment with antidiabetic biguanide drugs directly impacts the function of multiple pituitary cell types from two non-human primate models
  1111. Supplementary Information Biguanide-based synthesis of 1, 3, 5-triazine derivatives with anticancer activity and 1, 3, 5-triazine incorporated calcium citrate …
  1112. Ameliorative potential of biguanides on experimentally-induced lung fibrosis
  1113. Possibilities for using biguanides in cancer
  1114. THE EFFECTS OF AN INCRETIN MIMETIC AND BIGUANIDE ON BODY MASS INDEX AND THE COURSE OF GASTROESOPHAGEAL REFLUX DISEASE IN OBESE …
  1115. Abstract LB102: Hexyl-(cuban-1-yl-methyl)-biguanide (HCB) suppresses N-glycosylation of immune checkpoint proteins B7-H3 and B7-H4, reverses tumor hypoxia …
  1116. Abstract P2-02-11: Combinational treatment of biguanides and fatty acid β-oxidation inhibitor in triple-negative breast cancers
  1117. Cytotoxicity and molecular effects of biocidal disinfectants (quaternary ammonia, glutaraldehyde, poly (hexamethylene biguanide) hydrochloride PHMB) and their …
  1118. Coordination Compounds of Platinum and Palladium with Mixed Ligands (Usnic Acid and 1-(o-Tolyl) Biguanide)–Synthesis, Spectral Characterization and Biological …
  1119. THE DARK SIDE OF BIGUANIDES: A CASE REPORT ON METFORMIN-ASSOCIATED LACTIC ACIDOSIS (MALA): Received 2022-05-25; Accepted 2023-03-07; …
  1120. MP64-08 A NOVEL BIGUANIDE DERIVATIVE DRUG, IM176, INHIBITS PROSTATE CANCER
  1121. 1165-P: In Vitro Actions of a Novel Biguanide (BIG), NT1195, That Support Its Use in T2D
  1122. Evaluation of Hypoglycaemic Effects of Dipeptidyl Peptidase–4 Inhibitors and Biguanide on Type-2 Diabetic subjects: A six months trial
  1123. Towards Elucidating the Mechanism of Action of Biguanides
  1124. Potential role of biguanides and statins in the treatment of pituitary adenomas
  1125. Uptake of biguanides in mitochondria appears to be related to increased glucose uptake and medium acidification but not necessarily related to inhibition of growth of …
  1126. Magnetic properties of copper (II) complex with 1-(2-aminoethyl) biguanide
  1127. Biguanides exert antitumoral actions in pituitary tumor cells through AMPK-dependent and-independent mechanisms
  1128. A Review on Drug Related Problems in Type 2 DM with Combination of Sulfonylureas and Biguanides
  1129. Significance of the combination of biguanides and fatty acid β-oxidation inhibitors in triple-negative breast cancer
  1130. In vitro studies reveal a potential therapeutic role of the combination of biguanides and statins for the treatment of prostate cancer
  1131. TESTING THE ACTIVITY OF BIGUANIDES AND SOME NOVEL DESIGNED MOLECULES AGAINST SARS-COV-2 PROTEINS, IN SILICO STUDY
  1132. Abstract LB078: Hexyl-(cuban-1-yl-methyl)-biguanide (HCB) inhibits hormone therapy resistant breast cancer cells, in part by Inhibiting CYP3A4 arachidonic acid …
  1133. Effects of biguanides on mitochondrial permeability transition pore opening in intact brain cells
  1134. Translational and HIF-1a-Dependent Metabolic Reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides
  1135. Quantum-Chemical Study of the Coordination of Some Biguanides and their N-Deprotonated Derivatives Aidote François, Kuevi Urbain Amah*, Kpotin …
  1136. Complexes of Cu (II) with α-Ketoglutaric Acid and 1-(o-tolyl) Biguanide
  1137. 1187-P: The Novel Biguanide NT1195 Is an Oral Antidiabetes Drug for Patients with Kidney Disease
  1138. Translational and HIF1α-dependent metabolic reprograming underpin oncometabolome plasticity and synergy between oncogenic kinase inhibitors and biguanides
  1139. Synthesis, characterization and biological activity of the manganese complexes withα-ketoglutaric acid and 1-(o-tolyl) biguanide
  1140. … AND BIOLOGICAL ACTIVITY OF COMPOSITE COMBINATIONS OF Cu (II), Fe (III) AND Mn (III) WITH Α-KETOGLUTARIC ACID AND 1-(O-TOLYL) BIGUANIDE
  1141. Cellular gene delivery via polymeric biguanides
  1142. Repurposing HMG-CoA Reductase Inhibitors, L-Type Calcium Channel Antagonists and Biguanides in Serious Mental Illness: A Within-Individual Cohort Study in …
  1143. Antidiabetic biguanides are potent hypoxic radiosensitizers through targeting of mitochondrial respiration and re-oxygenation of tumor cells
Related Posts

Ketone Bodies

Calorie Restriction

Gsk3 (Inhibitor | Inhibitors)

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping